12552133	Potassium	Seidah NG	The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.	Proceedings of the National Academy of Sciences of the United States of America	2003	195
15207237	Potassium	Melman YF	KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity.	Neuron	2004	73
15728840	Potassium	Lim KL	Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.	The Journal of neuroscience 	2005	172
16428287	Potassium	Lazrak A	Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.	Proceedings of the National Academy of Sciences of the United States of America	2006	69
16959882	Potassium	Sansom OJ	Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2006	65
18292755	Potassium	Org T	The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression.	EMBO reports	2008	81
19349416	Potassium	Cha SK	Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho.	Molecular pharmacology	2009	65
19420365	Potassium	Bockenhauer D	Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.	The New England journal of medicine	2009	134
19458126	Potassium	Welling PA	A comprehensive guide to the ROMK potassium channel: form and function in health and disease.	American journal of physiology. Renal physiology	2009	51
19609347	Potassium	Adeyemo A	A genome-wide association study of hypertension and blood pressure in African Americans.	PLoS genetics	2009	161
21108436	Potassium	Eaton KW	Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.	Pediatric blood & cancer	2011	40
21190939	Potassium	Stawowczyk M	The interferon stimulated gene 54 promotes apoptosis.	The Journal of biological chemistry	2011	56
21289184	Potassium	Bardai FH	Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.	The Journal of neuroscience 	2011	53
21511946	Potassium	McLean JE	Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication.	The Journal of biological chemistry	2011	59
22266938	Potassium	Boyden LM	Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.	Nature	2012	120
24206662	Potassium	Shibata S	Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia.	Cell metabolism	2013	28
25540142	Potassium	Sepúlveda FV	Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.	Physiological reviews	2015	21
25838982	Potassium	Luettig J	Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.	Tissue barriers	2015	27
26039623	Potassium	Binia A	Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials.	Journal of hypertension	2015	16
26271406	Potassium	Hunt L	Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.	The Lancet. Infectious diseases	2015	38
26500246	Potassium	Luo J	Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.	Clinical journal of the American Society of Nephrology 	2016	17
26699492	Potassium	Olabisi OA	APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.	Proceedings of the National Academy of Sciences of the United States of America	2016	24
27826011	Potassium	Qiu YY	Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.	Pharmacological research	2016	11
28115470	Potassium	Lang B	Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.	Journal of neurology, neurosurgery, and psychiatry	2017	6
8665844	Sodium	Staub O	WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome.	The EMBO journal	1996	204
11696533	Sodium	Snyder PM	Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel.	The Journal of biological chemistry	2002	97
12671053	Sodium	Yang CL	WNK kinases regulate thiazide-sensitive Na-Cl cotransport.	The Journal of clinical investigation	2003	125
16166153	Sodium	Lou JY	Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.	The Journal of physiology	2005	69
17090678	Sodium	Crowley SD	Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.	Proceedings of the National Academy of Sciences of the United States of America	2006	197
17192275	Sodium	Gawenis LR	Colonic anion secretory defects and metabolic acidosis in mice lacking the NBC1 Na+/HCO3- cotransporter.	The Journal of biological chemistry	2007	64
17967977	Sodium	London B	Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.	Circulation	2007	104
18446519	Sodium	Ganapathy V	Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.	The AAPS journal	2008	54
19056867	Sodium	Gonzales PA	Large-scale proteomics and phosphoproteomics of urinary exosomes.	Journal of the American Society of Nephrology 	2009	160
19114657	Sodium	Wang Y	From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.	Proceedings of the National Academy of Sciences of the United States of America	2009	105
19228957	Sodium	Aman TK	Regulation of persistent Na current by interactions between beta subunits of voltage-gated Na channels.	The Journal of neuroscience 	2009	64
20351344	Sodium	Forman JP	Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.	Hypertension	2010	61
21441906	Sodium	Weiss J	Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.	Nature	2011	58
22223429	Sodium	Kovesdy CP	Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.	Circulation	2012	46
22771675	Sodium	Eirin A	Inflammatory and injury signals released from the post-stenotic human kidney.	European heart journal	2013	40
22922412	Sodium	McCurley A	Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.	Nature medicine	2012	71
23608660	Sodium	Hyndman KA	Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure.	Hypertension	2013	29
24127583	Sodium	Kusaba T	Differentiated kidney epithelial cells repair injured proximal tubule.	Proceedings of the National Academy of Sciences of the United States of America	2014	74
24158986	Sodium	Scialla JJ	Fibroblast growth factor-23 and cardiovascular events in CKD.	Journal of the American Society of Nephrology 	2014	76
24185693	Sodium	Trudu M	Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.	Nature medicine	2013	64
24265240	Sodium	Halestrap AP	Monocarboxylic acid transport.	Comprehensive Physiology	2013	42
24732974	Sodium	DeMarco VG	The pathophysiology of hypertension in patients with obesity.	Nature reviews. Endocrinology	2014	51
25100048	Sodium	Dahlmann A	Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients.	Kidney international	2015	21
25250572	Sodium	McCormick JA	Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.	The Journal of clinical investigation	2014	31
25788523	Sodium	Kasembeli AN	APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.	Journal of the American Society of Nephrology 	2015	40
26461968	Sodium	Newell KA	Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.	American journal of transplantation 	2015	18
26475588	Sodium	Chappell MC	Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?	American journal of physiology. Heart and circulatory physiology	2016	22
26863326	Sodium	Hadchouel J	Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.	Annual review of physiology	2016	17
27141060	Sodium	Norlander AE	Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension.	Hypertension	2016	14
11430829	Estradiol	Comijn J	The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.	Molecular cell	2001	391
12697741	Estradiol	Eghbali-Fatourechi G	Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.	The Journal of clinical investigation	2003	156
17060462	Estradiol	Evans AJ	VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.	Molecular and cellular biology	2007	76
18469803	Estradiol	Kanasaki K	Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.	Nature	2008	90
20089859	Estradiol	Pi J	Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity.	The Journal of biological chemistry	2010	68
20585629	Estradiol	Grey F	A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs.	PLoS pathogens	2010	75
21741057	Estradiol	Sienkiewicz E	Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.	Metabolism	2011	41
17229978	Androgens	Guzik TJ	Adipocytokines - novel link between inflammation and vascular function?	Journal of physiology and pharmacology 	2006	87
19212411	Androgens	Sreekumar A	Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.	Nature	2009	522
19345326	Androgens	Xu K	Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.	Cancer cell	2009	76
23993097	Androgens	Chang KH	A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.	Cell	2013	80
24423344	Androgens	O'Reilly MW	Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.	The Journal of clinical endocrinology and metabolism	2014	25
24706793	Androgens	McAllister JM	Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
11120762	Estrogens	Falahati-Nini A	Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.	The Journal of clinical investigation	2000	122
15361840	Estrogens	Usary J	Mutation of GATA3 in human breast tumors.	Oncogene	2004	80
15539556	Estrogens	Thomas P	Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.	Endocrinology	2005	359
16112414	Estrogens	Tsuchiya Y	Cytochrome P450-mediated metabolism of estrogens and its regulation in human.	Cancer letters	2005	99
19237579	Estrogens	Yang J	Lipocalin 2 promotes breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2009	85
21149639	Estrogens	Sandén C	G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments.	Molecular pharmacology	2011	41
22495674	Estrogens	Filardo EJ	Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.	Endocrinology	2012	73
23328895	Estrogens	Isoherranen N	Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?	Drug metabolism and disposition	2013	27
26919573	Estrogens	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
11826291	Aldosterone	Rossier BC	Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors.	Annual review of physiology	2002	100
12727933	Aldosterone	Chan JL	The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men.	The Journal of clinical investigation	2003	107
15583075	Aldosterone	Rahmouni K	Obesity-associated hypertension: new insights into mechanisms.	Hypertension	2005	127
17035613	Aldosterone	Rüster C	Renin-angiotensin-aldosterone system and progression of renal disease.	Journal of the American Society of Nephrology 	2006	69
17161262	Aldosterone	Rossi GP	A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.	Journal of the American College of Cardiology	2006	129
17182988	Aldosterone	Wang TJ	Multiple biomarkers for the prediction of first major cardiovascular events and death.	The New England journal of medicine	2006	248
17360471	Aldosterone	Ring AM	An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
17903302	Aldosterone	Levy D	Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness.	BMC medical genetics	2007	90
19029984	Aldosterone	Shibata S	Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease.	Nature medicine	2008	86
19487712	Aldosterone	Sowers JR	Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.	Annals of internal medicine	2009	65
19620517	Aldosterone	Pimenta E	Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.	Hypertension	2009	74
19690383	Aldosterone	Rozansky DJ	Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway.	The Journal of clinical investigation	2009	57
20200334	Aldosterone	Nishimoto K	Adrenocortical zonation in humans under normal and pathological conditions.	The Journal of clinical endocrinology and metabolism	2010	61
20234356	Aldosterone	Briet M	Aldosterone: effects on the kidney and cardiovascular system.	Nature reviews. Nephrology	2010	53
20393195	Aldosterone	Castrop H	Physiology of kidney renin.	Physiological reviews	2010	69
20442753	Aldosterone	Kotsis V	Mechanisms of obesity-induced hypertension.	Hypertension research 	2010	78
21693741	Aldosterone	de Boer IH	Temporal trends in the prevalence of diabetic kidney disease in the United States.	JAMA	2011	180
21699940	Aldosterone	Zhuo JL	New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.	Peptides	2011	44
21852580	Aldosterone	Arroyo JP	Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway.	Journal of the American Society of Nephrology 	2011	46
21852584	Aldosterone	de Borst MH	Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.	Journal of the American Society of Nephrology 	2011	54
22550170	Aldosterone	Castañeda-Bueno M	Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.	Proceedings of the National Academy of Sciences of the United States of America	2012	75
23348737	Aldosterone	Ronzaud C	Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.	The Journal of clinical investigation	2013	29
23558162	Aldosterone	He FJ	Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.	BMJ	2013	133
23594269	Aldosterone	Baudrand R	High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome.	Clinical endocrinology	2014	27
23633321	Aldosterone	He FJ	Effect of longer-term modest salt reduction on blood pressure.	The Cochrane database of systematic reviews	2013	39
23774812	Aldosterone	Brown NJ	Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.	Nature reviews. Nephrology	2013	33
23883676	Aldosterone	Xue B	Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen.	American journal of physiology. Regulatory, integrative and comparative physiology	2013	27
24948743	Aldosterone	Yu AS	Claudins and the kidney.	Journal of the American Society of Nephrology 	2015	19
25176603	Aldosterone	Lee SY	Therapeutic targets for treating fibrotic kidney diseases.	Translational research 	2015	24
25400162	Aldosterone	Kandzari DE	Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.	European heart journal	2015	48
25767285	Aldosterone	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
26240369	Aldosterone	Nishimoto K	Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.	Proceedings of the National Academy of Sciences of the United States of America	2015	32
26668301	Aldosterone	Jaisser F	Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology.	Pharmacological reviews	2016	17
26936907	Aldosterone	Lindhardt M	Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.	BMJ open	2016	14
27263398	Aldosterone	D'Agati VD	Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.	Nature reviews. Nephrology	2016	27
27470431	Aldosterone	Gnudi L	Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.	Trends in endocrinology and metabolism	2016	16
7587918	Blood Glucose	Ohkubo Y	Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.	Diabetes research and clinical practice	1995	343
15767618	Blood Glucose	Boden G	Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.	Annals of internal medicine	2005	74
17065355	Blood Glucose	Van den Berghe G	Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.	Diabetes	2006	77
17088535	Blood Glucose	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	186
21241070	Blood Glucose	Graham GG	Clinical pharmacokinetics of metformin.	Clinical pharmacokinetics	2011	127
21531886	Blood Glucose	Bakris GL	Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.	Mayo Clinic proceedings	2011	35
21617108	Blood Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Diabetes care	2011	73
21617152	Blood Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	58
22355316	Blood Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22723582	Blood Glucose	Barton FB	Improvement in outcomes of clinical islet transplantation: 1999-2010.	Diabetes care	2012	145
24226519	Blood Glucose	Rieg T	Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.	American journal of physiology. Renal physiology	2014	32
25341005	Blood Glucose	Vallon V	The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.	Annual review of medicine	2015	25
9204908	Insulin	Brunn GJ	Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin.	Science	1997	232
9793760	Insulin	Duckworth WC	Insulin degradation: progress and potential.	Endocrine reviews	1998	155
10645822	Insulin	Hanson RL	Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.	American journal of epidemiology	2000	101
10774732	Insulin	Man HY	Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.	Neuron	2000	155
11151758	Insulin	Weyer C	Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.	Diabetologia	2000	137
11445664	Insulin	Vozarova B	Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.	Obesity research	2001	88
15205477	Insulin	Cohen HY	Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.	Science	2004	554
15564314	Insulin	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	102
15677759	Insulin	Boucher J	Apelin, a newly identified adipokine up-regulated by insulin and obesity.	Endocrinology	2005	87
17470699	Insulin	Ford ES	Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents.	Circulation	2007	95
17586614	Insulin	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
17995453	Insulin	Chen S	Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators.	The Biochemical journal	2008	61
18094066	Insulin	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18465361	Insulin	Renehan AG	Obesity and cancer: pathophysiological and biological mechanisms.	Archives of physiology and biochemistry	2008	90
18854395	Insulin	Bikle D	Nonclassic actions of vitamin D.	The Journal of clinical endocrinology and metabolism	2009	163
20055708	Insulin	Gloerich M	Epac: defining a new mechanism for cAMP action.	Annual review of pharmacology and toxicology	2010	163
20889126	Insulin	Welsh GI	Insulin signaling to the glomerular podocyte is critical for normal kidney function.	Cell metabolism	2010	100
21435450	Insulin	Link A	Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans.	The American journal of pathology	2011	36
22241293	Insulin	Jeschke MG	Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response.	Annals of surgery	2012	33
23932846	Insulin	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	47
25673412	Insulin	Shungin D	New genetic loci link adipose and insulin biology to body fat distribution.	Nature	2015	208
25673413	Insulin	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
26696633	Insulin	Gommers LM	Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?	Diabetes	2016	15
9531176	Phosphorus	Block GA	Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.	American journal of kidney diseases 	1998	283
15698460	Phosphorus	Young EW	Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.	Kidney international	2005	118
16735491	Phosphorus	Antoniucci DM	Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.	The Journal of clinical endocrinology and metabolism	2006	109
17502528	Phosphorus	Dhingra R	Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.	Archives of internal medicine	2007	185
18417722	Phosphorus	Mathew S	The mechanism of phosphorus as a cardiovascular risk factor in CKD.	Journal of the American Society of Nephrology 	2008	66
19965919	Phosphorus	Shimada T	Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.	The Journal of clinical endocrinology and metabolism	2010	64
20176609	Phosphorus	Nasrallah MM	Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.	Nephrology, dialysis, transplantation 	2010	46
22031097	Phosphorus	Stubbs JR	Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.	Journal of bone and mineral research 	2012	38
23520205	Phosphorus	Dominguez JR	Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes.	Journal of the American Society of Nephrology 	2013	29
26908770	Phosphorus	Brandenburg VM	Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.	Nephrology, dialysis, transplantation 	2017	9
12952917	Phosphates	Riminucci M	FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.	The Journal of clinical investigation	2003	134
14988389	Phosphates	Larsson T	Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.	Endocrinology	2004	118
15504939	Phosphates	Reynolds JL	Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.	Journal of the American Society of Nephrology 	2004	147
15579309	Phosphates	Sitara D	Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.	Matrix biology 	2004	128
16037577	Phosphates	Hruska KA	Bone morphogenetic proteins in vascular calcification.	Circulation research	2005	82
16869716	Phosphates	Burnett SM	Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.	Journal of bone and mineral research 	2006	115
17964265	Phosphates	Nowotny M	Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription.	Molecular cell	2007	107
18687639	Phosphates	Gutiérrez OM	Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.	The New England journal of medicine	2008	398
19033649	Phosphates	Quarles LD	Endocrine functions of bone in mineral metabolism regulation.	The Journal of clinical investigation	2008	91
19679205	Phosphates	Pereira RC	Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.	Bone	2009	64
19844248	Phosphates	Razzaque MS	The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.	Nature reviews. Endocrinology	2009	86
20593414	Phosphates	Jüppner H	FGF-23: More than a regulator of renal phosphate handling?	Journal of bone and mineral research 	2010	45
21115613	Phosphates	Hu MC	Klotho deficiency causes vascular calcification in chronic kidney disease.	Journal of the American Society of Nephrology 	2011	197
21454719	Phosphates	Cunningham J	Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.	Clinical journal of the American Society of Nephrology 	2011	58
21482743	Phosphates	Tangri N	A predictive model for progression of chronic kidney disease to kidney failure.	JAMA	2011	157
21673295	Phosphates	Isakova T	Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.	JAMA	2011	241
22115958	Phosphates	Yeung BH	Evolution and roles of stanniocalcin.	Molecular and cellular endocrinology	2012	36
22228304	Phosphates	Cassago A	Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2012	53
22298654	Phosphates	Martin A	Regulation and function of the FGF23/klotho endocrine pathways.	Physiological reviews	2012	98
22421513	Phosphates	Quarles LD	Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.	Experimental cell research	2012	48
22622492	Phosphates	Wolf M	Update on fibroblast growth factor 23 in chronic kidney disease.	Kidney international	2012	68
23389416	Phosphates	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	61
23774819	Phosphates	Kuro-o M	Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.	Nature reviews. Nephrology	2013	31
24466013	Phosphates	Sakan H	Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.	PloS one	2014	31
24668259	Phosphates	Kestenbaum B	Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.	Circulation. Heart failure	2014	23
24686452	Phosphates	Scialla JJ	Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.	Nature reviews. Nephrology	2014	30
24695641	Phosphates	Six I	Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.	PloS one	2014	21
24920722	Phosphates	Mathew JS	Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).	Circulation	2014	22
25695404	Phosphates	Xu Y	Molecular basis of Klotho: from gene to function in aging.	Endocrine reviews	2015	28
25916871	Phosphates	Schlieper G	Vascular calcification in chronic kidney disease: an update.	Nephrology, dialysis, transplantation 	2016	11
25925688	Phosphates	Keyzer CA	Calcification Propensity and Survival among Renal Transplant Recipients.	Journal of the American Society of Nephrology 	2016	11
25967123	Phosphates	Isakova T	Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.	Journal of the American Society of Nephrology 	2015	25
26047794	Phosphates	Schlingmann KP	Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.	Journal of the American Society of Nephrology 	2016	17
26059012	Phosphates	Moe SM	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.	Circulation	2015	30
26567701	Phosphates	Degirolamo C	Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.	Nature reviews. Drug discovery	2016	29
26681731	Phosphates	Leifheit-Nestler M	Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.	Nephrology, dialysis, transplantation 	2016	16
27368672	Phosphates	Johansson S	A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.	Clinical and experimental nephrology	2017	11
27457912	Phosphates	Singh S	Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.	Kidney international	2016	18
27838783	Phosphates	Kuro-O M	The FGF23 and Klotho system beyond mineral metabolism.	Clinical and experimental nephrology	2017	7
27887750	Phosphates	Webster AC	Chronic Kidney Disease.	Lancet	2017	16
12050285	Peptides	Gnanapavan S	The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.	The Journal of clinical endocrinology and metabolism	2002	192
15820677	Peptides	Rajan S	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Cell	2005	74
16622600	Peptides	Werle M	Strategies to improve plasma half life time of peptide and protein drugs.	Amino acids	2006	63
17979302	Peptides	Luca S	Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR.	Biochemistry	2007	167
18056480	Peptides	Farhat K	Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.	Journal of leukocyte biology	2008	83
20150539	Peptides	Ling XB	Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.	Journal of the American Society of Nephrology 	2010	41
20534508	Peptides	Lorieau JL	The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
20595511	Peptides	Wild D	Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.	Journal of nuclear medicine 	2010	44
23297075	Peptides	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	32
23754528	Peptides	Schlapschy M	PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins.	Protein engineering, design & selection 	2013	29
25589610	Peptides	Schanstra JP	Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.	Journal of the American Society of Nephrology 	2015	30
2167835	Glucose	Nehlin JO	Yeast MIG1 repressor is related to the mammalian early growth response and Wilms' tumour finger proteins.	The EMBO journal	1990	152
8247074	Glucose	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	212
10491414	Glucose	Weyer C	The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.	The Journal of clinical investigation	1999	293
10571771	Glucose	Gilbert RE	The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?	Kidney international	1999	121
11375115	Glucose	Delerive P	Peroxisome proliferator-activated receptors in inflammation control.	The Journal of endocrinology	2001	142
11588148	Glucose	Weinstein LS	Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.	Endocrine reviews	2001	99
11812755	Glucose	Vozarova B	High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.	Diabetes	2002	90
12874439	Glucose	Lee HB	Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.	Journal of the American Society of Nephrology 	2003	89
15315937	Glucose	Higgins DF	Hypoxic induction of Ctgf is directly mediated by Hif-1.	American journal of physiology. Renal physiology	2004	83
15938030	Glucose	Schena FP	Pathogenetic mechanisms of diabetic nephropathy.	Journal of the American Society of Nephrology 	2005	85
16250043	Glucose	Bugianesi E	Insulin resistance: a metabolic pathway to chronic liver disease.	Hepatology	2005	117
16306358	Glucose	Rahmoune H	Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.	Diabetes	2005	113
16702987	Glucose	Briscoe CP	Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.	British journal of pharmacology	2006	96
17015487	Glucose	Lang F	(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.	Physiological reviews	2006	167
17222166	Glucose	Wright EM	Active sugar transport in health and disease.	Journal of internal medicine	2007	97
17551816	Glucose	Semenza GL	HIF-1 mediates the Warburg effect in clear cell renal carcinoma.	Journal of bioenergetics and biomembranes	2007	80
18055507	Glucose	Jensen RT	International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.	Pharmacological reviews	2008	103
18220694	Glucose	Ziyadeh FN	Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.	Current diabetes reviews	2008	91
18347614	Glucose	Lawrence MC	The roles of MAPKs in disease.	Cell research	2008	60
18716028	Glucose	Wang Q	MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.	FASEB journal 	2008	128
18776125	Glucose	Lindenmeyer MT	Proteinuria and hyperglycemia induce endoplasmic reticulum stress.	Journal of the American Society of Nephrology 	2008	62
19295913	Glucose	Guo T	Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.	PloS one	2009	76
19357717	Glucose	Bakris GL	Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.	Kidney international	2009	52
19470762	Glucose	Sudarshan S	Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.	Molecular and cellular biology	2009	78
19581401	Glucose	Kato M	MicroRNAs and their role in progressive kidney diseases.	Clinical journal of the American Society of Nephrology 	2009	67
19625659	Glucose	Elmasri H	Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.	FASEB journal 	2009	61
19808921	Glucose	Brown RJ	Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion.	Diabetes care	2009	52
19934006	Glucose	Oudit GY	Human recombinant ACE2 reduces the progression of diabetic nephropathy.	Diabetes	2010	71
19963135	Glucose	Yang Y	UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.	Cancer genetics and cytogenetics	2010	45
20067797	Glucose	Du B	High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells.	FEBS letters	2010	48
20103708	Glucose	Jiang T	The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.	Diabetes	2010	78
20185635	Glucose	Ortiz-Muñoz G	Suppressors of cytokine signaling abrogate diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	40
20226138	Glucose	Clar C	Self-monitoring of blood glucose in type 2 diabetes: systematic review.	Health technology assessment	2010	53
20508640	Glucose	Chao EC	SGLT2 inhibition--a novel strategy for diabetes treatment.	Nature reviews. Drug discovery	2010	80
20546255	Glucose	Gerich JE	Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.	Diabetic medicine 	2010	82
20944545	Glucose	Yvan-Charvet L	Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.	Kidney international	2011	40
20966399	Glucose	Mirza MA	Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
20980548	Glucose	Hummel CS	Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.	American journal of physiology. Cell physiology	2011	49
21358696	Glucose	Mather A	Glucose handling by the kidney.	Kidney international. Supplement	2011	42
21606218	Glucose	Abdul-Ghani MA	Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.	Endocrine reviews	2011	69
21638209	Glucose	Samarakoon R	TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.	Cell and tissue research	2012	39
21723505	Glucose	Yadav H	Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.	Cell metabolism	2011	117
21911743	Glucose	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	58
22021706	Glucose	Lin M	Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.	Journal of the American Society of Nephrology 	2012	69
22335797	Glucose	Vallon V	Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.	Annual review of physiology	2012	54
22997257	Glucose	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	39
23249272	Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23439261	Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
24065789	Glucose	Abdul-Ghani MA	Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans.	Diabetes	2013	27
24113348	Glucose	Liu J	Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.	Cellular signalling	2014	23
24204837	Glucose	Alvarez ML	Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.	PloS one	2013	25
24223694	Glucose	Barutta F	Urinary exosomal microRNAs in incipient diabetic nephropathy.	PloS one	2013	49
24356594	Glucose	de Boer IH	Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.	Diabetes care	2014	26
24504108	Glucose	White NM	Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.	Oncotarget	2014	28
24508027	Glucose	Wong N	PKM2 contributes to cancer metabolism.	Cancer letters	2015	42
24529566	Glucose	Geerlings S	Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria.	Diabetes research and clinical practice	2014	22
24558077	Glucose	Bakris GL	Microalbuminuria as a risk predictor in diabetes: the continuing saga.	Diabetes care	2014	22
24622320	Glucose	Tahrani AA	SGLT inhibitors in management of diabetes.	The lancet. Diabetes & endocrinology	2013	28
24673844	Glucose	De Nicola L	Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.	American journal of kidney diseases 	2014	24
24676639	Glucose	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	31
24925721	Glucose	Yoo TH	Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.	Journal of the American Society of Nephrology 	2015	25
24954193	Glucose	Lee P	Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans.	Diabetes	2014	60
25009184	Glucose	Zhang P	Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
25035342	Glucose	Lim S	Links between ectopic fat and vascular disease in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	32
25104103	Glucose	Wilding JP	The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.	Metabolism	2014	23
25185947	Glucose	Cypess AM	Brown fat in humans: consensus points and experimental guidelines.	Cell metabolism	2014	38
25304002	Glucose	Vrhovac I	Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.	Pflugers Archiv 	2015	23
25421524	Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25637831	Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25695398	Glucose	Jensen TE	PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.	The Biochemical journal	2015	15
25787249	Glucose	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	32
26604280	Glucose	Mudaliar S	Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.	Diabetes care	2015	25
26814590	Glucose	Krashes MJ	Melanocortin-4 receptor-regulated energy homeostasis.	Nature neuroscience	2016	26
26942205	Glucose	Jia Y	miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.	Journal of diabetes research	2016	15
27941935	Glucose	DeFronzo RA	Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.	Nature reviews. Nephrology	2017	8
27964927	Glucose	Li X	Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.	Experimental cell research	2017	5
28007348	Glucose	El-Khatib FH	Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.	Lancet	2017	10
28120497	Glucose	Neal B	Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2017	12
28314735	Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
2154335	Zinc	Call KM	Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.	Cell	1990	273
2154702	Zinc	Gessler M	Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.	Nature	1990	187
10097139	Zinc	Lammich S	Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.	Proceedings of the National Academy of Sciences of the United States of America	1999	208
10458613	Zinc	Bell AC	The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.	Cell	1999	357
10935639	Zinc	Van Esch H	GATA3 haplo-insufficiency causes human HDR syndrome.	Nature	2000	101
17065149	Zinc	Chowanadisai W	Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency.	The Journal of biological chemistry	2006	64
18562529	Zinc	Stanley BJ	Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.	Journal of virology	2008	52
19400752	Zinc	Lichten LA	Mammalian zinc transporters: nutritional and physiologic regulation.	Annual review of nutrition	2009	170
19470664	Zinc	Kim HJ	Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.	Genome research	2009	146
21599891	Zinc	Thirumoorthy N	A review of metallothionein isoforms and their role in pathophysiology.	World journal of surgical oncology	2011	39
22386240	Zinc	Wang G	Expression of microRNAs in the urine of patients with bladder cancer.	Clinical genitourinary cancer	2012	49
25126789	Zinc	Deng W	Reactivation of developmentally silenced globin genes by forced chromatin looping.	Cell	2014	82
26637978	Zinc	Boycott KM	Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8.	American journal of human genetics	2015	20
26840484	Zinc	Davies B	Re-engineering the zinc fingers of PRDM9 reverses hybrid sterility in mice.	Nature	2016	29
27083996	Zinc	Ghirlando R	CTCF: making the right connections.	Genes & development	2016	39
27624489	Zinc	Zhou D	Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.	Journal of the American Society of Nephrology 	2017	7
28481222	Zinc	Lin W	Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.	The Journal of clinical investigation	2017	10
9482913	Iron	Zhou XY	HFE gene knockout produces mouse model of hereditary hemochromatosis.	Proceedings of the National Academy of Sciences of the United States of America	1998	113
9718377	Iron	Besarab A	The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.	The New England journal of medicine	1998	274
9884342	Iron	Yachie A	Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.	The Journal of clinical investigation	1999	257
12433676	Iron	Nemeth E	Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.	Blood	2003	263
15124018	Iron	Nemeth E	IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.	The Journal of clinical investigation	2004	477
15670845	Iron	Hvidberg V	The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake.	FEBS letters	2005	77
15671438	Iron	Papanikolaou G	Hepcidin in iron overload disorders.	Blood	2005	94
15711640	Iron	Mori K	Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.	The Journal of clinical investigation	2005	229
15831703	Iron	Cooperman SS	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	Blood	2005	69
15886319	Iron	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	110
16775460	Iron	Schmidt-Ott KM	Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia.	Current opinion in nephrology and hypertension	2006	62
17229906	Iron	Tracz MJ	Physiology and pathophysiology of heme: implications for kidney disease.	Journal of the American Society of Nephrology 	2007	84
17342180	Iron	Mori K	Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage.	Kidney international	2007	93
17488680	Iron	Origa R	Liver iron concentrations and urinary hepcidin in beta-thalassemia.	Haematologica	2007	85
17540841	Iron	Lin L	Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.	Blood	2007	77
17699374	Iron	Wish JB	Assessing iron status: beyond serum ferritin and transferrin saturation.	Clinical journal of the American Society of Nephrology 	2006	65
17721544	Iron	Tanno T	High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	Nature medicine	2007	193
17891154	Iron	Hierro A	Functional architecture of the retromer cargo-recognition complex.	Nature	2007	85
18166790	Iron	Kemna EH	Hepcidin: from discovery to differential diagnosis.	Haematologica	2008	55
18511687	Iron	Shi H	A cytosolic iron chaperone that delivers iron to ferritin.	Science	2008	105
18628991	Iron	Swinkels DW	Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.	PloS one	2008	54
18689548	Iron	Ganz T	Immunoassay for human serum hepcidin.	Blood	2008	160
18725016	Iron	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.	American journal of kidney diseases 	2008	79
19176796	Iron	Provenzano R	Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.	Clinical journal of the American Society of Nephrology 	2009	45
19212416	Iron	Ashby DR	Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.	Kidney international	2009	52
19406957	Iron	Zaritsky J	Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2009	61
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
19650691	Iron	Tolosano E	Heme scavenging and the other facets of hemopexin.	Antioxidants & redox signaling	2010	63
19805308	Iron	Huang ML	Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
19907144	Iron	Nemeth E	The role of hepcidin in iron metabolism.	Acta haematologica	2009	68
20189278	Iron	Babitt JL	Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.	American journal of kidney diseases 	2010	44
20444740	Iron	Haase VH	Hypoxic regulation of erythropoiesis and iron metabolism.	American journal of physiology. Renal physiology	2010	59
20448661	Iron	Linehan WM	The genetic basis of kidney cancer: a metabolic disease.	Nature reviews. Urology	2010	180
20739637	Iron	Kroot JJ	Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.	Clinical chemistry	2010	42
20887198	Iron	Ganz T	Hepcidin and disorders of iron metabolism.	Annual review of medicine	2011	121
21427356	Iron	Josson S	β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.	Cancer research	2011	44
21989113	Iron	Kroot JJ	Hepcidin in human iron disorders: diagnostic implications.	Clinical chemistry	2011	42
22055506	Iron	Nandal A	Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.	Cell metabolism	2011	43
22290531	Iron	Sun CC	Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.	American journal of hematology	2012	42
22306005	Iron	Ganz T	Hepcidin and iron homeostasis.	Biochimica et biophysica acta	2012	166
22327295	Iron	Noinaj N	Structural basis for iron piracy by pathogenic Neisseria.	Nature	2012	58
22513004	Iron	Chakraborty S	The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.	Biochimica et biophysica acta	2012	99
22998881	Iron	Rostoker G	Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.	The American journal of medicine	2012	33
23114598	Iron	Liu Q	Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.	The Journal of clinical investigation	2012	50
23291219	Iron	Haase VH	Regulation of erythropoiesis by hypoxia-inducible factors.	Blood reviews	2013	70
24186312	Iron	Fung E	Manipulation of the hepcidin pathway for therapeutic purposes.	Haematologica	2013	32
24552640	Iron	Ruchala P	The pathophysiology and pharmacology of hepcidin.	Trends in pharmacological sciences	2014	20
24843120	Iron	Frey AG	Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24867675	Iron	Wolf M	Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.	Current opinion in nephrology and hypertension	2014	23
25306858	Iron	Kühn LC	Iron regulatory proteins and their role in controlling iron metabolism.	Metallomics 	2015	22
26055355	Iron	Koury MJ	Anaemia in kidney disease: harnessing hypoxia responses for therapy.	Nature reviews. Nephrology	2015	27
26250435	Iron	Kalra PA	A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.	Nephrology, dialysis, transplantation 	2016	12
26314490	Iron	Lopez A	Iron deficiency anaemia.	Lancet	2016	38
26561626	Iron	Peyrin-Biroulet L	Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review.	The American journal of clinical nutrition	2015	19
26794443	Iron	Xie Y	Ferroptosis: process and function.	Cell death and differentiation	2016	40
26906116	Iron	Lever JM	Heme Oxygenase-1 in Kidney Health and Disease.	Antioxidants & redox signaling	2016	12
27321965	Iron	Shepshelovich D	Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.	American journal of kidney diseases 	2016	12
27650732	Iron	Pergola PE	Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.	Kidney international	2016	13
28060743	Iron	González N	2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.	Oncotarget	2017	5
9038151	Adenosine Triphosphate	Rassendren F	The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.	The Journal of biological chemistry	1997	114
9105039	Adenosine Triphosphate	Rodríguez A	Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells.	The Journal of cell biology	1997	131
9316396	Adenosine Triphosphate	Okada Y	Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor.	The American journal of physiology	1997	115
10346816	Adenosine Triphosphate	Paull TT	Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex.	Genes & development	1999	172
11707406	Adenosine Triphosphate	Kim M	Proteomic and functional evidence for a P2X7 receptor signalling complex.	The EMBO journal	2001	94
12270951	Adenosine Triphosphate	North RA	Molecular physiology of P2X receptors.	Physiological reviews	2002	783
12438266	Adenosine Triphosphate	Cuezva JM	The bioenergetic signature of cancer: a marker of tumor progression.	Cancer research	2002	96
12556361	Adenosine Triphosphate	Leipziger J	Control of epithelial transport via luminal P2 receptors.	American journal of physiology. Renal physiology	2003	78
14523092	Adenosine Triphosphate	Jiang LH	Subunit arrangement in P2X receptors.	The Journal of neuroscience 	2003	77
14530494	Adenosine Triphosphate	Leonard GD	The role of ABC transporters in clinical practice.	The oncologist	2003	147
14576852	Adenosine Triphosphate	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	169
14713298	Adenosine Triphosphate	Bijur GN	Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.	Journal of neurochemistry	2003	94
15109305	Adenosine Triphosphate	Praskova M	Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.	The Biochemical journal	2004	114
15383652	Adenosine Triphosphate	Wagner CA	Renal vacuolar H+-ATPase.	Physiological reviews	2004	105
15841208	Adenosine Triphosphate	Timmins JM	Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.	The Journal of clinical investigation	2005	149
15845415	Adenosine Triphosphate	Leslie EM	Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.	Toxicology and applied pharmacology	2005	197
17005808	Adenosine Triphosphate	Ray AS	Mechanism of active renal tubular efflux of tenofovir.	Antimicrobial agents and chemotherapy	2006	82
17392515	Adenosine Triphosphate	Doller A	Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.	Molecular biology of the cell	2007	71
17785580	Adenosine Triphosphate	Guo C	Evidence for functional P2X4/P2X7 heteromeric receptors.	Molecular pharmacology	2007	58
19158351	Adenosine Triphosphate	Cirillo P	Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.	Journal of the American Society of Nephrology 	2009	59
19593530	Adenosine Triphosphate	Kostenko S	Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology.	Cellular and molecular life sciences 	2009	89
20181807	Adenosine Triphosphate	Workeneh BT	Review of muscle wasting associated with chronic kidney disease.	The American journal of clinical nutrition	2010	49
20430975	Adenosine Triphosphate	Novarino G	Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis.	Science	2010	43
21132003	Adenosine Triphosphate	Morris MR	Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.	Oncogene	2011	56
21813754	Adenosine Triphosphate	Chan DA	Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality.	Science translational medicine	2011	92
22158596	Adenosine Triphosphate	Petkov GV	Role of potassium ion channels in detrusor smooth muscle function and dysfunction.	Nature reviews. Urology	2011	50
22179786	Adenosine Triphosphate	Gupta S	Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops.	Nature structural & molecular biology	2011	50
23434541	Adenosine Triphosphate	Chen K	ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.	The international journal of biochemistry & cell biology	2013	33
23688078	Adenosine Triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23878142	Adenosine Triphosphate	Asgari E	C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation.	Blood	2013	53
24669934	Adenosine Triphosphate	Lindoso RS	Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.	Stem cells and development	2014	24
24746669	Adenosine Triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24875192	Adenosine Triphosphate	Pearce D	Collecting duct principal cell transport processes and their regulation.	Clinical journal of the American Society of Nephrology 	2015	36
25326666	Adenosine Triphosphate	Ronan B	A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.	Nature chemical biology	2014	56
25475361	Adenosine Triphosphate	Nigam SK	What do drug transporters really do?	Nature reviews. Drug discovery	2015	55
25879284	Adenosine Triphosphate	Goldberg EL	Drivers of age-related inflammation and strategies for healthspan extension.	Immunological reviews	2015	18
26818947	Adenosine Triphosphate	Imamura M	Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.	Nature communications	2016	13
28437620	Adenosine Triphosphate	Jellinger PS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.	Endocrine practice 	2017	14
9457173	Dopamine	Missale C	Dopamine receptors: from structure to function.	Physiological reviews	1998	553
12953054	Dopamine	Sariola H	Novel functions and signalling pathways for GDNF.	Journal of cell science	2003	134
13679416	Dopamine	Morón JA	Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.	The Journal of neuroscience 	2003	78
20858707	Dopamine	Duan H	Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.	The Journal of pharmacology and experimental therapeutics	2010	45
23065479	Dopamine	Dale RC	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.	Brain 	2012	49
23363473	Dopamine	Rilstone JJ	Brain dopamine-serotonin vesicular transport disease and its treatment.	The New England journal of medicine	2013	28
24431445	Dopamine	Murphy JA	Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines.	The Journal of neuroscience 	2014	33
25588018	Dopamine	Liechti M	Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.	Swiss medical weekly	2015	19
2158863	Cysteine	Schall TJ	Molecular cloning and expression of a receptor for human tumor necrosis factor.	Cell	1990	150
6091915	Cysteine	Yamamoto T	The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.	Cell	1984	272
7958843	Cysteine	Kumar S	Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.	Genes & development	1994	120
9096311	Cysteine	Rattner A	A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.	Proceedings of the National Academy of Sciences of the United States of America	1997	115
9461608	Cysteine	Ichimura T	Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.	The Journal of biological chemistry	1998	249
10506580	Cysteine	Duncan MR	Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP.	FASEB journal 	1999	118
11113131	Cysteine	Park CH	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.	The Journal of biological chemistry	2001	352
12371953	Cysteine	Himmelfarb J	The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.	Kidney international	2002	192
17071618	Cysteine	Aracena-Parks P	Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1.	The Journal of biological chemistry	2006	76
18164316	Cysteine	Lin SC	Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.	Journal of molecular biology	2008	53
20213804	Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
22394518	Cysteine	Yu K	Explaining calcium-dependent gating of anoctamin-1 chloride channels requires a revised topology.	Circulation research	2012	59
22581845	Cysteine	Smith MA	Calpains, mitochondria, and apoptosis.	Cardiovascular research	2012	46
24491257	Cysteine	Kimura H	The physiological role of hydrogen sulfide and beyond.	Nitric oxide 	2014	34
25205735	Cysteine	Kao L	Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.	Journal of the American Society of Nephrology 	2015	25
11274445	Bicarbonates	Royaux IE	Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion.	Proceedings of the National Academy of Sciences of the United States of America	2001	119
19394734	Bicarbonates	Shah SN	Serum bicarbonate levels and the progression of kidney disease: a cohort study.	American journal of kidney diseases 	2009	53
23489677	Bicarbonates	Dobre M	Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.	American journal of kidney diseases 	2013	37
26477665	Bicarbonates	Kraut JA	Metabolic Acidosis of CKD: An Update.	American journal of kidney diseases 	2016	13
12081584	Parathyroid Hormone	Chertow GM	Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.	Kidney international	2002	187
12808462	Parathyroid Hormone	Vilardaga JP	Measurement of the millisecond activation switch of G protein-coupled receptors in living cells.	Nature biotechnology	2003	113
14500804	Parathyroid Hormone	Black DM	The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.	The New England journal of medicine	2003	178
15284207	Parathyroid Hormone	Bai X	Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.	Endocrinology	2004	74
15284307	Parathyroid Hormone	Block GA	Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.	Journal of the American Society of Nephrology 	2004	423
15814832	Parathyroid Hormone	Slinin Y	Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.	Journal of the American Society of Nephrology 	2005	79
16738536	Parathyroid Hormone	Melamed ML	Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.	Kidney international	2006	83
17091124	Parathyroid Hormone	Levin A	Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.	Kidney international	2007	262
18514987	Parathyroid Hormone	Tentori F	Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).	American journal of kidney diseases 	2008	163
18667733	Parathyroid Hormone	Regidor DL	Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.	Journal of the American Society of Nephrology 	2008	58
19595349	Parathyroid Hormone	Fraser WD	Hyperparathyroidism.	Lancet	2009	105
19923405	Parathyroid Hormone	Riccardi D	Physiology and pathophysiology of the calcium-sensing receptor in the kidney.	American journal of physiology. Renal physiology	2010	57
20059333	Parathyroid Hormone	Bergwitz C	Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.	Annual review of medicine	2010	97
20466670	Parathyroid Hormone	Floege J	Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.	Nephrology, dialysis, transplantation 	2011	70
20614473	Parathyroid Hormone	Kalantar-Zadeh K	Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.	Journal of bone and mineral research 	2010	46
21159838	Parathyroid Hormone	Sai AJ	Relationship between vitamin D, parathyroid hormone, and bone health.	The Journal of clinical endocrinology and metabolism	2011	45
21183586	Parathyroid Hormone	Moe SM	Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2011	69
21389978	Parathyroid Hormone	Isakova T	Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.	Kidney international	2011	225
21406649	Parathyroid Hormone	Palmer SC	Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.	JAMA	2011	132
21436289	Parathyroid Hormone	Wolf M	Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.	Journal of the American Society of Nephrology 	2011	70
21570529	Parathyroid Hormone	Taylor EN	Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.	American heart journal	2011	37
21939825	Parathyroid Hormone	Kestenbaum B	Vitamin D, parathyroid hormone, and cardiovascular events among older adults.	Journal of the American College of Cardiology	2011	59
22052943	Parathyroid Hormone	Wesseling-Perry K	Early skeletal and biochemical alterations in pediatric chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2012	38
22648296	Parathyroid Hormone	Bosworth CR	The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.	Kidney international	2012	35
22895520	Parathyroid Hormone	Seiler S	Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.	Kidney international	2013	26
23129826	Parathyroid Hormone	Pavik I	Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.	Nephrology, dialysis, transplantation 	2013	36
23243213	Parathyroid Hormone	Scialla JJ	Mineral metabolites and CKD progression in African Americans.	Journal of the American Society of Nephrology 	2013	31
23652549	Parathyroid Hormone	Hu MC	Klotho and chronic kidney disease.	Contributions to nephrology	2013	28
26321176	Parathyroid Hormone	Sprague SM	Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.	American journal of kidney diseases 	2016	13
28097355	Parathyroid Hormone	Block GA	Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.	JAMA	2017	6
28097356	Parathyroid Hormone	Block GA	Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.	JAMA	2017	7
16647419	Glycosaminoglycans	Harmatz P	Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.	The Journal of pediatrics	2006	77
17606547	Glycosaminoglycans	Wraith JE	Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).	Pediatrics	2007	58
18502162	Glycosaminoglycans	Harmatz P	Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.	Molecular genetics and metabolism	2008	63
11773613	Vasopressins	Nielsen S	Aquaporins in the kidney: from molecules to medicine.	Physiological reviews	2002	213
16964248	Vasopressins	van der Horst A	FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.	Nature cell biology	2006	155
17090781	Vasopressins	Xu C	Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.	American journal of physiology. Renal physiology	2007	66
23438973	Vasopressins	Bankir L	Vasopressin: a novel target for the prevention and retardation of kidney disease?	Nature reviews. Nephrology	2013	30
25493947	Vasopressins	Torres VE	Vasopressin receptor antagonists, heart failure, and polycystic kidney disease.	Annual review of medicine	2015	15
12490682	Urea	Eknoyan G	Effect of dialysis dose and membrane flux in maintenance hemodialysis.	The New England journal of medicine	2002	213
17928589	Urea	Burg MB	Cellular response to hyperosmotic stresses.	Physiological reviews	2007	162
19214027	Urea	Hsu HJ	Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.	The American journal of the medical sciences	2009	45
21750109	Urea	Rafnar T	European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.	Human molecular genetics	2011	47
23258127	Urea	Vaziri ND	Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.	American journal of nephrology	2013	35
25700560	Urea	Polletta L	SIRT5 regulation of ammonia-induced autophagy and mitophagy.	Autophagy	2015	25
26867814	Urea	Obi Y	Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.	American journal of kidney diseases 	2016	24
27070809	Urea	Miller PG	Design and demonstration of a pumpless 14 compartment microphysiological system.	Biotechnology and bioengineering	2016	14
11030331	Bile Acids and Salts	Lu TT	Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.	Molecular cell	2000	294
16749856	Bile Acids and Salts	Zollner G	Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.	Molecular pharmaceutics	2006	61
17404808	Bile Acids and Salts	Alrefai WA	Bile acid transporters: structure, function, regulation and pathophysiological implications.	Pharmaceutical research	2007	68
23217254	Bile Acids and Salts	Angelin B	Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.	Cell metabolism	2012	55
25919227	Bile Acids and Salts	O'Keefe SJ	Fat, fibre and cancer risk in African Americans and rural Africans.	Nature communications	2015	75
14978175	Cyclophosphamide	Ruf RG	Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.	Journal of the American Society of Nephrology 	2004	77
16796719	Cyclophosphamide	Fudaba Y	Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.	American journal of transplantation 	2006	72
19581388	Cyclophosphamide	Pan YZ	MicroRNAs regulate CYP3A4 expression via direct and indirect targeting.	Drug metabolism and disposition	2009	69
20935625	Cyclophosphamide	Gu C	Direct dynamin-actin interactions regulate the actin cytoskeleton.	The EMBO journal	2010	66
22842478	Cyclophosphamide	Walter S	Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.	Nature medicine	2012	236
28405610	Cyclophosphamide	Katewa A	Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.	JCI insight	2017	5
19092120	Doxorubicin	Ronconi E	Regeneration of glomerular podocytes by human renal progenitors.	Journal of the American Society of Nephrology 	2009	155
19628668	Doxorubicin	Dai C	Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.	Journal of the American Society of Nephrology 	2009	129
20505657	Doxorubicin	Kang YS	Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.	Kidney international	2010	45
21839714	Doxorubicin	Nijenhuis T	Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.	The American journal of pathology	2011	46
23278683	Doxorubicin	Tacar O	Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.	The Journal of pharmacy and pharmacology	2013	184
24590287	Doxorubicin	Daehn I	Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.	The Journal of clinical investigation	2014	57
25689250	Doxorubicin	Mallipattu SK	Krüppel-like factor 6 regulates mitochondrial function in the kidney.	The Journal of clinical investigation	2015	17
12853585	Glucocorticoids	Sarwal M	Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.	The New England journal of medicine	2003	143
16600922	Glucocorticoids	Morley JE	Cachexia: pathophysiology and clinical relevance.	The American journal of clinical nutrition	2006	124
21756023	Glucocorticoids	Mele C	MYO1E mutations and childhood familial focal segmental glomerulosclerosis.	The New England journal of medicine	2011	74
24029422	Glucocorticoids	Wu J	Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.	Journal of the American Society of Nephrology 	2014	34
14514731	Cisplatin	Mishra J	Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury.	Journal of the American Society of Nephrology 	2003	382
14600030	Cisplatin	Ichimura T	Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.	American journal of physiology. Renal physiology	2004	122
16951202	Cisplatin	Zhang S	Organic cation transporters are determinants of oxaliplatin cytotoxicity.	Cancer research	2006	77
17021608	Cisplatin	Zhou H	Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.	Kidney international	2006	78
18256356	Cisplatin	Zhang B	TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.	Journal of the American Society of Nephrology 	2008	76
18509321	Cisplatin	Zhou H	Urinary exosomal transcription factors, a new class of biomarkers for renal disease.	Kidney international	2008	53
19387469	Cisplatin	Vaidya VS	A rapid urine test for early detection of kidney injury.	Kidney international	2009	54
20049901	Cisplatin	Morigi M	Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.	Stem cells	2010	51
21160028	Cisplatin	Brooks C	Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.	American journal of physiology. Cell physiology	2011	48
22431999	Cisplatin	Bruno S	Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.	PloS one	2012	135
22440905	Cisplatin	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
23082760	Cisplatin	Tomasoni S	Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.	Stem cells and development	2013	74
23618405	Cisplatin	Zhou Y	Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.	Stem cell research & therapy	2013	95
24449906	Cisplatin	Lee YS	Human Pol ζ purified with accessory subunits is active in translesion DNA synthesis and complements Pol η in cisplatin bypass.	Proceedings of the National Academy of Sciences of the United States of America	2014	45
25165721	Cisplatin	Ozkok A	Pathophysiology of cisplatin-induced acute kidney injury.	BioMed research international	2014	54
28164431	Cisplatin	Ragni E	Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication.	Stem cells	2017	6
9389420	Hydrocortisone	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	157
20462908	Hydrocortisone	Seltzer LJ	Social vocalizations can release oxytocin in humans.	Proceedings. Biological sciences	2010	55
22735432	Hydrocortisone	Ebbeling CB	Effects of dietary composition on energy expenditure during weight-loss maintenance.	JAMA	2012	68
22778226	Hydrocortisone	Meyer JS	Minireview: Hair cortisol: a novel biomarker of hypothalamic-pituitary-adrenocortical activity.	Endocrinology	2012	41
26067718	Hydrocortisone	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
27483065	Hydrocortisone	Gordon AC	Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.	JAMA	2016	15
15841207	Catecholamines	Xu J	Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.	The Journal of clinical investigation	2005	68
17200167	Catecholamines	Timmers HJ	Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.	The Journal of clinical endocrinology and metabolism	2007	62
19092146	Catecholamines	Greenfield JR	Modulation of blood pressure by central melanocortinergic pathways.	The New England journal of medicine	2009	121
11566918	Oxygen	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	112
12086861	Oxygen	Maranchie JK	The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.	Cancer cell	2002	130
14691554	Oxygen	Kondo K	Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.	PLoS biology	2003	197
14985465	Oxygen	Zimmer M	Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.	Molecular cancer research 	2004	82
15104534	Oxygen	Marxsen JH	Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.	The Biochemical journal	2004	80
15611513	Oxygen	Kim WY	Role of VHL gene mutation in human cancer.	Journal of clinical oncology 	2004	224
15802268	Oxygen	Phillips RJ	Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.	The Journal of biological chemistry	2005	95
16234508	Oxygen	Wenger RH	Integration of oxygen signaling at the consensus HRE.	Science's STKE 	2005	279
16291837	Oxygen	Nangaku M	Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.	Journal of the American Society of Nephrology 	2006	207
16394109	Oxygen	Galkina E	Leukocyte recruitment and vascular injury in diabetic nephropathy.	Journal of the American Society of Nephrology 	2006	73
16407130	Oxygen	Percy MJ	A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2006	87
16417408	Oxygen	Chi JT	Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.	PLoS medicine	2006	195
16446448	Oxygen	Vartanian V	The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
16585181	Oxygen	Esteban MA	Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.	Cancer research	2006	85
17220275	Oxygen	Yan Q	The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.	Molecular and cellular biology	2007	62
17255293	Oxygen	Kaelin WG Jr	The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.	Clinical cancer research 	2007	88
17479184	Oxygen	Frangogiannis NG	Chemokines in ischemia and reperfusion.	Thrombosis and haemostasis	2007	69
18222169	Oxygen	Suzuki C	Participation of autophagy in renal ischemia/reperfusion injury.	Biochemical and biophysical research communications	2008	57
18418042	Oxygen	Higgins DF	Hypoxia-inducible factor signaling in the development of tissue fibrosis.	Cell cycle	2008	58
19017170	Oxygen	Brines M	Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.	Journal of internal medicine	2008	79
19252501	Oxygen	Wang Y	Regulation of endocytosis via the oxygen-sensing pathway.	Nature medicine	2009	74
19281826	Oxygen	Roberts CK	Oxidative stress and metabolic syndrome.	Life sciences	2009	114
20194303	Oxygen	Gloviczki ML	Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.	Hypertension	2010	47
20718759	Oxygen	Elmarakby AA	Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.	Cardiovascular therapeutics	2012	65
21115615	Oxygen	Bernhardt WM	Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.	Journal of the American Society of Nephrology 	2010	72
21900452	Oxygen	Bussolati B	Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance.	American journal of physiology. Renal physiology	2012	30
22200433	Oxygen	Vaziri ND	Effect of uremia on structure and function of immune system.	Journal of renal nutrition 	2012	42
22344686	Oxygen	Chau BN	MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.	Science translational medicine	2012	130
22363487	Oxygen	Du R	Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.	PloS one	2012	49
22458843	Oxygen	Zhu P	Angiopoietin-like 4: a decade of research.	Bioscience reports	2012	43
22937071	Oxygen	Feikin DR	Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010.	PloS one	2012	49
23181475	Oxygen	Hansell P	Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension.	Clinical and experimental pharmacology & physiology	2013	28
23357108	Oxygen	Stenvinkel P	Chronic kidney disease: a clinical model of premature aging.	American journal of kidney diseases 	2013	29
23640890	Oxygen	Tan Q	Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.	The Journal of biological chemistry	2013	29
23699409	Oxygen	Young RM	Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.	Genes & development	2013	54
25383540	Oxygen	Zuo W	p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.	Nature	2015	78
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25533676	Oxygen	Gossage L	VHL, the story of a tumour suppressor gene.	Nature reviews. Cancer	2015	75
25829424	Oxygen	Qiu B	HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.	Cancer discovery	2015	32
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
9186882	Cholesterol	Hunsicker LG	Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.	Kidney international	1997	122
9987089	Cholesterol	Zimmermann J	Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.	Kidney international	1999	136
10333910	Cholesterol	-	Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.	Diabetes care	1999	172
10692273	Cholesterol	Yeun JY	C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.	American journal of kidney diseases 	2000	95
10802740	Cholesterol	Tsujishita Y	Structure and lipid transport mechanism of a StAR-related domain.	Nature structural biology	2000	103
11260414	Cholesterol	Kambham N	Obesity-related glomerulopathy: an emerging epidemic.	Kidney international	2001	169
11752030	Cholesterol	Zoccali C	Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.	Journal of the American Society of Nephrology 	2002	92
12788992	Cholesterol	Perkins BA	Regression of microalbuminuria in type 1 diabetes.	The New England journal of medicine	2003	158
15625072	Cholesterol	Muntner P	Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.	Journal of the American Society of Nephrology 	2005	93
15928087	Cholesterol	Garcia-Calvo M	The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).	Proceedings of the National Academy of Sciences of the United States of America	2005	138
16403839	Cholesterol	Vaziri ND	Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.	American journal of physiology. Renal physiology	2006	90
17079490	Cholesterol	Huber TB	Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17700640	Cholesterol	Keller S	CD24 is a marker of exosomes secreted into urine and amniotic fluid.	Kidney international	2007	78
18295053	Cholesterol	Zhang L	Prevalence and factors associated with CKD: a population study from Beijing.	American journal of kidney diseases 	2008	59
18440684	Cholesterol	Foster MC	Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.	American journal of kidney diseases 	2008	62
18584872	Cholesterol	Wong TY	Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study.	Ophthalmology	2008	71
19121469	Cholesterol	Kovesdy CP	Why is protein-energy wasting associated with mortality in chronic kidney disease?	Seminars in nephrology	2009	50
20172445	Cholesterol	Stevens LA	Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2010	58
20631351	Cholesterol	Calkin AC	Liver x receptor signaling pathways and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2010	75
20807315	Cholesterol	Rosenbaum AI	Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches.	Journal of neurochemistry	2011	69
21414625	Cholesterol	Recio-Mayoral A	Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.	Atherosclerosis	2011	39
21804091	Cholesterol	Holzer M	Uremia alters HDL composition and function.	Journal of the American Society of Nephrology 	2011	59
21852664	Cholesterol	Thomas G	Metabolic syndrome and kidney disease: a systematic review and meta-analysis.	Clinical journal of the American Society of Nephrology 	2011	93
23111824	Cholesterol	Hallan SI	Age and association of kidney measures with mortality and end-stage renal disease.	JAMA	2012	103
23141484	Cholesterol	Yamamoto S	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.	Journal of the American College of Cardiology	2012	43
23233737	Cholesterol	Lee BH	Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.	Cancer research	2013	26
23351925	Cholesterol	Anderson TJ	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.	The Canadian journal of cardiology	2013	162
23690465	Cholesterol	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	42
23704105	Cholesterol	Rundek T	Traditional risk factors are not major contributors to the variance in carotid intima-media thickness.	Stroke	2013	25
24056686	Cholesterol	Leebmann J	Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.	Circulation	2013	29
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24371263	Cholesterol	Herman-Edelstein M	Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.	Journal of lipid research	2014	38
24722445	Cholesterol	de Zeeuw D	The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	42
24832097	Cholesterol	Rahman M	Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.	Clinical journal of the American Society of Nephrology 	2014	22
24861084	Cholesterol	Fornoni A	Lipid biology of the podocyte--new perspectives offer new opportunities.	Nature reviews. Nephrology	2014	22
24918789	Cholesterol	Usiskin K	Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results.	Postgraduate medicine	2014	29
25589482	Cholesterol	Inzucchi SE	SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.	Diabetes & vascular disease research	2015	58
26718096	Cholesterol	Banach M	Lipids, blood pressure and kidney update 2015.	Lipids in health and disease	2015	17
26924057	Cholesterol	Bowe B	Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.	Kidney international	2016	15
27100393	Cholesterol	Medina-Remón A	Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial.	British journal of clinical pharmacology	2017	13
27515591	Cholesterol	Bowe B	High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.	Clinical journal of the American Society of Nephrology 	2016	13
28153991	Cholesterol	Lew J	Sex-Based Differences in Cardiometabolic Biomarkers.	Circulation	2017	7
28286957	Cholesterol	Chen H	Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.	Journal of proteome research	2017	8
951142	Creatinine	Schwartz GJ	A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.	Pediatrics	1976	307
8413456	Creatinine	Lewis EJ	The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.	The New England journal of medicine	1993	517
10231453	Creatinine	Stenvinkel P	Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.	Kidney international	1999	168
10550418	Creatinine	Meyer TW	Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.	Diabetologia	1999	111
10873868	Creatinine	Coll E	Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.	American journal of kidney diseases 	2000	92
10886574	Creatinine	Muntner P	Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.	Kidney international	2000	108
11386930	Creatinine	Schiffmann R	Enzyme replacement therapy in Fabry disease: a randomized controlled trial.	JAMA	2001	158
11728958	Creatinine	Kalantar-Zadeh K	A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.	American journal of kidney diseases 	2001	108
11912263	Creatinine	Mattix HJ	Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race.	Journal of the American Society of Nephrology 	2002	97
11916939	Creatinine	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	103
11961019	Creatinine	Paniagua R	Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.	Journal of the American Society of Nephrology 	2002	103
12081572	Creatinine	Rastaldi MP	Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.	Kidney international	2002	89
12148093	Creatinine	Dharnidharka VR	Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.	American journal of kidney diseases 	2002	234
12515748	Creatinine	Shlipak MG	Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.	Circulation	2003	133
12528874	Creatinine	Kyle RA	Review of 1027 patients with newly diagnosed multiple myeloma.	Mayo Clinic proceedings	2003	283
12709468	Creatinine	Imai Y	Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.	JAMA	2003	106
13679476	Creatinine	Hoek FJ	A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.	Nephrology, dialysis, transplantation 	2003	76
14633152	Creatinine	Larsson T	Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.	Kidney international	2003	149
14715185	Creatinine	Forman DE	Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.	Journal of the American College of Cardiology	2004	115
14981598	Creatinine	Parikh CR	Urinary interleukin-18 is a marker of human acute tubular necrosis.	American journal of kidney diseases 	2004	118
15086483	Creatinine	Knight EL	Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.	Kidney international	2004	174
15327406	Creatinine	Herget-Rosenthal S	Early detection of acute renal failure by serum cystatin C.	Kidney international	2004	163
15327410	Creatinine	Szczech LA	The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.	Kidney international	2004	81
15607309	Creatinine	Filler G	Cystatin C as a marker of GFR--history, indications, and future research.	Clinical biochemistry	2005	118
15611490	Creatinine	Rule AD	Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.	Annals of internal medicine	2004	205
15615823	Creatinine	Poggio ED	Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.	Journal of the American Society of Nephrology 	2005	99
15809451	Creatinine	Greipp PR	International staging system for multiple myeloma.	Journal of clinical oncology 	2005	372
15809461	Creatinine	Sarnak MJ	Cystatin C concentration as a risk factor for heart failure in older adults.	Annals of internal medicine	2005	96
15811456	Creatinine	Mishra J	Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.	Lancet	2005	502
15882252	Creatinine	Levey AS	Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).	Kidney international	2005	390
15901858	Creatinine	Shlipak MG	Cystatin C and the risk of death and cardiovascular events among elderly persons.	The New England journal of medicine	2005	307
15941879	Creatinine	Noakes M	Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.	The American journal of clinical nutrition	2005	73
15961546	Creatinine	Grubb A	Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.	Clinical chemistry	2005	73
16148039	Creatinine	Parikh CR	Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.	Journal of the American Society of Nephrology 	2005	110
16267155	Creatinine	Shlipak MG	Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.	Journal of the American Society of Nephrology 	2006	69
16319383	Creatinine	Muthukumar T	Messenger RNA for FOXP3 in the urine of renal-allograft recipients.	The New England journal of medicine	2005	121
16408129	Creatinine	Eriksen BO	The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.	Kidney international	2006	86
16408133	Creatinine	Rule AD	Glomerular filtration rate estimated by cystatin C among different clinical presentations.	Kidney international	2006	75
16528543	Creatinine	Mishra J	Kidney NGAL is a novel early marker of acute injury following transplantation.	Pediatric nephrology	2006	75
16697315	Creatinine	Smith GL	Renal impairment and outcomes in heart failure: systematic review and meta-analysis.	Journal of the American College of Cardiology	2006	111
16710348	Creatinine	Parikh CR	Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.	Kidney international	2006	132
16827865	Creatinine	Parikh CR	Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.	American journal of transplantation 	2006	115
16908914	Creatinine	Shlipak MG	Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.	Annals of internal medicine	2006	145
16931980	Creatinine	Wagener G	Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery.	Anesthesiology	2006	112
17082756	Creatinine	Chonchol M	25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey.	Kidney international	2007	64
17190862	Creatinine	Ix JH	Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.	Circulation	2007	75
17316593	Creatinine	Roos JF	Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis.	Clinical biochemistry	2007	58
17332152	Creatinine	Levey AS	Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.	Clinical chemistry	2007	373
17457094	Creatinine	Szczech LA	Microalbuminuria in HIV infection.	AIDS	2007	59
17656479	Creatinine	Fliser D	Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.	Journal of the American Society of Nephrology 	2007	180
17699320	Creatinine	Furth SL	Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.	Clinical journal of the American Society of Nephrology 	2006	113
17962588	Creatinine	Khatri M	Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).	Stroke	2007	60
18059454	Creatinine	Han WK	Urinary biomarkers in the early diagnosis of acute kidney injury.	Kidney international	2008	111
18076931	Creatinine	Thompson RH	Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.	The Journal of urology	2008	96
18094679	Creatinine	Coca SG	Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.	Kidney international	2008	148
18094680	Creatinine	Portilla D	Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.	Kidney international	2008	82
18235143	Creatinine	Baxmann AC	Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.	Clinical journal of the American Society of Nephrology 	2008	85
18287807	Creatinine	Ling W	Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.	Nephron. Clinical practice	2008	62
18295055	Creatinine	Stevens LA	Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.	American journal of kidney diseases 	2008	349
18337554	Creatinine	Bennett M	Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study.	Clinical journal of the American Society of Nephrology 	2008	164
18379258	Creatinine	Wheeler DS	Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.	Critical care medicine	2008	78
18385206	Creatinine	Astor BC	Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.	American journal of epidemiology	2008	79
18511168	Creatinine	Elsayed EF	Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.	American journal of kidney diseases 	2008	54
18519927	Creatinine	Nickolas TL	Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.	Annals of internal medicine	2008	166
18585836	Creatinine	Kurella Tamura M	Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.	American journal of kidney diseases 	2008	103
18649981	Creatinine	Wagener G	Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery.	American journal of kidney diseases 	2008	54
18650797	Creatinine	Koyner JL	Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery.	Kidney international	2008	77
19001197	Creatinine	Rifkin DE	Rapid kidney function decline and mortality risk in older adults.	Archives of internal medicine	2008	106
19114878	Creatinine	Haase-Fielitz A	Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.	Critical care medicine	2009	75
19118301	Creatinine	Moers C	Machine perfusion or cold storage in deceased-donor kidney transplantation.	The New England journal of medicine	2009	85
19119287	Creatinine	Stevens LA	Factors other than glomerular filtration rate affect serum cystatin C levels.	Kidney international	2009	120
19158356	Creatinine	Schwartz GJ	New equations to estimate GFR in children with CKD.	Journal of the American Society of Nephrology 	2009	415
19176795	Creatinine	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2009	112
19262355	Creatinine	Labarga P	Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.	AIDS	2009	62
19349297	Creatinine	Bagshaw SM	A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury.	Nephrology, dialysis, transplantation 	2009	53
19406962	Creatinine	Han WK	Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery.	Clinical journal of the American Society of Nephrology 	2009	86
19430482	Creatinine	Köttgen A	Multiple loci associated with indices of renal function and chronic kidney disease.	Nature genetics	2009	192
19536068	Creatinine	Tzvetkov MV	The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.	Clinical pharmacology and therapeutics	2009	50
19570208	Creatinine	Liu KD	Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study.	Critical care	2009	48
19608703	Creatinine	de Brito-Ashurst I	Bicarbonate supplementation slows progression of CKD and improves nutritional status.	Journal of the American Society of Nephrology 	2009	122
19720929	Creatinine	Jensen HK	Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.	Journal of clinical oncology 	2009	105
19762491	Creatinine	Hall IE	IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.	Journal of the American Society of Nephrology 	2010	85
19838127	Creatinine	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	44
19850388	Creatinine	Haase M	Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.	American journal of kidney diseases 	2009	249
19956924	Creatinine	Bagshaw SM	Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.	Intensive care medicine	2010	92
19956925	Creatinine	Cruz DN	Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.	Intensive care medicine	2010	68
20056755	Creatinine	McIlroy DR	Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.	Clinical journal of the American Society of Nephrology 	2010	44
20100732	Creatinine	Závada J	A comparison of three methods to estimate baseline creatinine for RIFLE classification.	Nephrology, dialysis, transplantation 	2010	49
20117878	Creatinine	Jentzmik F	Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.	European urology	2010	48
20123318	Creatinine	Aghel A	Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.	Journal of cardiac failure	2010	54
20124537	Creatinine	Hemmelgarn BR	Relation between kidney function, proteinuria, and adverse outcomes.	JAMA	2010	214
20124891	Creatinine	Schneider J	Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit.	Critical care medicine	2010	51
20138414	Creatinine	White SL	Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.	American journal of kidney diseases 	2010	59
20164823	Creatinine	Endre ZH	Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).	Kidney international	2010	71
20189275	Creatinine	Matsushita K	Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.	American journal of kidney diseases 	2010	67
20212276	Creatinine	Ix JH	Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study.	Circulation	2010	41
20214409	Creatinine	Stangier J	Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.	Clinical pharmacokinetics	2010	94
20332356	Creatinine	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	48
20383145	Creatinine	Chambers JC	Genetic loci influencing kidney function and chronic kidney disease.	Nature genetics	2010	90
20383146	Creatinine	Köttgen A	New loci associated with kidney function and chronic kidney disease.	Nature genetics	2010	260
20385436	Creatinine	Bellomo G	Association of uric acid with change in kidney function in healthy normotensive individuals.	American journal of kidney diseases 	2010	45
20397003	Creatinine	Mårtensson J	Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury.	Intensive care medicine	2010	64
20406069	Creatinine	Devarajan P	Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.	Biomarkers in medicine	2010	62
20441712	Creatinine	Black C	Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.	Health technology assessment	2010	47
20458318	Creatinine	Vaidya VS	Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.	Nature biotechnology	2010	111
20483451	Creatinine	Chronic Kidney Disease Prognosis Consortium.	Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.	Lancet	2010	651
20485332	Creatinine	Garin EH	Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.	Kidney international	2010	42
20522536	Creatinine	Adler SG	Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.	Clinical journal of the American Society of Nephrology 	2010	48
20525986	Creatinine	Shah RV	Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.	European journal of heart failure	2010	55
20557989	Creatinine	Stevens LA	Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.	American journal of kidney diseases 	2010	112
20558561	Creatinine	Siew ED	Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes.	Clinical journal of the American Society of Nephrology 	2010	43
20562094	Creatinine	Macedo E	Defining urine output criterion for acute kidney injury in critically ill patients.	Nephrology, dialysis, transplantation 	2011	36
20581391	Creatinine	Serra AL	Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.	The New England journal of medicine	2010	129
20609093	Creatinine	Devarajan P	Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury.	Nephrology	2010	69
20682604	Creatinine	Upadhyay A	Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.	Nephrology, dialysis, transplantation 	2011	39
20686651	Creatinine	Gudbjartsson DF	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	PLoS genetics	2010	50
20709438	Creatinine	Choi A	Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.	American journal of kidney diseases 	2010	45
20798258	Creatinine	Koyner JL	Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.	Clinical journal of the American Society of Nephrology 	2010	96
20837926	Creatinine	Rahman IA	Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?	Circulation	2010	52
20930086	Creatinine	Perico N	Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.	Clinical journal of the American Society of Nephrology 	2011	76
20935115	Creatinine	de Geus HR	Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.	American journal of respiratory and critical care medicine	2011	64
21098347	Creatinine	Roussel R	Metformin use and mortality among patients with diabetes and atherothrombosis.	Archives of internal medicine	2010	54
21107446	Creatinine	Stevens LA	Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.	Kidney international	2011	53
21164029	Creatinine	Peralta CA	Cystatin C identifies chronic kidney disease patients at higher risk for complications.	Journal of the American Society of Nephrology 	2011	63
21232094	Creatinine	Englberger L	Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery.	Critical care	2011	46
21242477	Creatinine	James MT	Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.	Circulation	2011	49
21252674	Creatinine	Devarajan P	Biomarkers for the early detection of acute kidney injury.	Current opinion in pediatrics	2011	56
21300375	Creatinine	Krawczeski CD	Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass.	The Journal of pediatrics	2011	46
21338849	Creatinine	Stevens LA	Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2011	40
21368745	Creatinine	Trachtman H	A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.	Kidney international	2011	68
21412214	Creatinine	Singer E	Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.	Kidney international	2011	41
21482744	Creatinine	Peralta CA	Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.	JAMA	2011	102
21511111	Creatinine	Haase M	The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.	Journal of the American College of Cardiology	2011	135
21601330	Creatinine	Zhang Z	Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.	American journal of kidney diseases 	2011	47
21646496	Creatinine	Alonso A	Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.	Circulation	2011	78
21672124	Creatinine	Graefe-Mody U	Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).	Diabetes, obesity & metabolism	2011	44
21779943	Creatinine	Fu WJ	Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.	Endocrine	2012	30
21836147	Creatinine	Parikh CR	Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery.	Journal of the American Society of Nephrology 	2011	93
21931561	Creatinine	Liu CT	Genetic association for renal traits among participants of African ancestry reveals new loci for renal function.	PLoS genetics	2011	54
21944663	Creatinine	Hecking M	Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).	American journal of kidney diseases 	2012	34
22034506	Creatinine	Gutiérrez OM	Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.	Clinical journal of the American Society of Nephrology 	2011	42
22034509	Creatinine	Hall IE	Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis.	Clinical journal of the American Society of Nephrology 	2011	38
22093507	Creatinine	Krawczeski CD	Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.	Journal of the American College of Cardiology	2011	55
22095948	Creatinine	Ralib AM	Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury.	Journal of the American Society of Nephrology 	2012	41
22194591	Creatinine	Udy AA	Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.	Chest	2012	49
22240130	Creatinine	Nickolas TL	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.	Journal of the American College of Cardiology	2012	75
22269279	Creatinine	Pickkers P	Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.	Critical care	2012	35
22305758	Creatinine	Astor BC	Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.	American journal of kidney diseases 	2012	50
22311920	Creatinine	Ferguson MA	Established and emerging markers of kidney function.	Clinical chemistry	2012	30
22328173	Creatinine	Brunner HI	Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.	Arthritis and rheumatism	2012	32
22383693	Creatinine	Koyner JL	Biomarkers predict progression of acute kidney injury after cardiac surgery.	Journal of the American Society of Nephrology 	2012	69
22403278	Creatinine	Bomback AS	Eculizumab for dense deposit disease and C3 glomerulonephritis.	Clinical journal of the American Society of Nephrology 	2012	72
22418979	Creatinine	Nejat M	Some biomarkers of acute kidney injury are increased in pre-renal acute injury.	Kidney international	2012	43
22457086	Creatinine	Shimamura Y	Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.	Clinical and experimental nephrology	2012	38
22622496	Creatinine	Schwartz GJ	Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.	Kidney international	2012	58
22658574	Creatinine	Anderson AH	Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2012	68
22703926	Creatinine	Ix JH	Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).	Journal of the American College of Cardiology	2012	86
22762315	Creatinine	Inker LA	Estimating glomerular filtration rate from serum creatinine and cystatin C.	The New England journal of medicine	2012	532
22770927	Creatinine	Roshanravan B	A prospective study of frailty in nephrology-referred patients with CKD.	American journal of kidney diseases 	2012	54
22824630	Creatinine	Kalayjian RC	Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.	AIDS	2012	41
22832513	Creatinine	Lipkowitz MS	Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.	Kidney international	2013	74
22842844	Creatinine	Inker LA	Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.	Journal of acquired immune deficiency syndromes	2012	32
22889713	Creatinine	Kilbride HS	Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly.	American journal of kidney diseases 	2013	34
22936784	Creatinine	Alexander RT	Kidney stones and kidney function loss: a cohort study.	BMJ	2012	40
22951890	Creatinine	Ärnlöv J	Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.	Kidney international	2013	39
23024164	Creatinine	Gupta J	Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.	Clinical journal of the American Society of Nephrology 	2012	56
23027318	Creatinine	Schaeffner ES	Two novel equations to estimate kidney function in persons aged 70 years or older.	Annals of internal medicine	2012	77
23115326	Creatinine	Vanmassenhove J	Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.	Nephrology, dialysis, transplantation 	2013	67
23273292	Creatinine	Metra M	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.	Journal of the American College of Cardiology	2013	63
23360717	Creatinine	Nitsch D	Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.	BMJ	2013	53
23375078	Creatinine	Singer E	Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications.	Acta physiologica	2013	29
23388612	Creatinine	Kashani K	Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.	Critical care	2013	174
23411786	Creatinine	Parekh DJ	Tolerance of the human kidney to isolated controlled ischemia.	Journal of the American Society of Nephrology 	2013	32
23423253	Creatinine	Rule AD	Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.	Kidney international	2013	40
23454726	Creatinine	Waldron JL	Vitamin D: a negative acute phase reactant.	Journal of clinical pathology	2013	32
23464594	Creatinine	Yale JF	Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.	Diabetes, obesity & metabolism	2013	94
23540260	Creatinine	Kim HR	Circulating α-klotho levels in CKD and relationship to progression.	American journal of kidney diseases 	2013	30
23599408	Creatinine	Parikh CR	Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.	Clinical journal of the American Society of Nephrology 	2013	57
23619125	Creatinine	Grams ME	Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.	American journal of kidney diseases 	2013	29
23667695	Creatinine	Wen MS	Decrease in irisin in patients with chronic kidney disease.	PloS one	2013	28
23689653	Creatinine	McCullough PA	Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.	Contributions to nephrology	2013	36
23886566	Creatinine	Sharma SG	The modern spectrum of renal biopsy findings in patients with diabetes.	Clinical journal of the American Society of Nephrology 	2013	31
23939543	Creatinine	Krolewski AS	Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.	Diabetes care	2014	50
24004120	Creatinine	Shlipak MG	Cystatin C versus creatinine in determining risk based on kidney function.	The New England journal of medicine	2013	139
24144866	Creatinine	Lv LL	CD2AP mRNA in urinary exosome as biomarker of kidney disease.	Clinica chimica acta; international journal of clinical chemistry	2014	23
24206458	Creatinine	Parsa A	APOL1 risk variants, race, and progression of chronic kidney disease.	The New England journal of medicine	2013	175
24211404	Creatinine	Zubiri I	Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.	Journal of proteomics	2014	32
24311704	Creatinine	Portale AA	Disordered FGF23 and mineral metabolism in children with CKD.	Clinical journal of the American Society of Nephrology 	2014	23
24375576	Creatinine	Belcher JM	Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.	Hepatology	2014	37
24404151	Creatinine	Shao X	Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis.	PloS one	2014	26
24480828	Creatinine	Kaushal GP	Challenges and advances in the treatment of AKI.	Journal of the American Society of Nephrology 	2014	20
24485147	Creatinine	Levey AS	GFR estimation: from physiology to public health.	American journal of kidney diseases 	2014	51
24499951	Creatinine	Solomon MM	Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.	AIDS	2014	39
24596084	Creatinine	Kawamura T	A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.	Nephrology, dialysis, transplantation 	2014	21
24623144	Creatinine	Wise AF	Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury.	American journal of physiology. Renal physiology	2014	23
24652789	Creatinine	Lu JL	Association of body mass index with outcomes in patients with CKD.	Journal of the American Society of Nephrology 	2014	43
24675717	Creatinine	Meersch M	Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.	PloS one	2014	63
24840668	Creatinine	Soveri I	Measuring GFR: a systematic review.	American journal of kidney diseases 	2014	29
24904085	Creatinine	Sabbisetti VS	Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.	Journal of the American Society of Nephrology 	2014	45
24965700	Creatinine	Yale JF	Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.	Diabetes, obesity & metabolism	2014	29
25029429	Creatinine	Langefeld CD	Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.	Kidney international	2015	33
25054777	Creatinine	Freedman BI	APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.	Kidney international	2015	30
25063425	Creatinine	An Y	Renal histologic changes and the outcome in patients with diabetic nephropathy.	Nephrology, dialysis, transplantation 	2015	17
25075773	Creatinine	Gallagher SM	Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery.	Kidney international	2015	17
25145934	Creatinine	Lai JY	MicroRNA-21 in glomerular injury.	Journal of the American Society of Nephrology 	2015	27
25195004	Creatinine	Wasung ME	Biomarkers of renal function, which and when?	Clinica chimica acta; international journal of clinical chemistry	2015	31
25272234	Creatinine	Pavkov ME	Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.	Kidney international	2015	19
25311702	Creatinine	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
25316431	Creatinine	Fufaa GD	Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.	Diabetologia	2015	21
25348707	Creatinine	Bennett MR	Pediatric reference ranges for acute kidney injury biomarkers.	Pediatric nephrology	2015	17
25393378	Creatinine	Naik RP	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	30
25527647	Creatinine	Fan L	Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.	Journal of the American Society of Nephrology 	2015	24
25530108	Creatinine	Le Quintrec M	Eculizumab for treatment of rapidly progressive C3 glomerulopathy.	American journal of kidney diseases 	2015	21
25619485	Creatinine	Carlier M	Comparison of different equations to assess glomerular filtration in critically ill patients.	Intensive care medicine	2015	15
25651366	Creatinine	Floege J	Development and validation of a predictive mortality risk score from a European hemodialysis cohort.	Kidney international	2015	20
25710660	Creatinine	Levey AS	Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.	JAMA	2015	32
25855775	Creatinine	Zhang WR	Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery.	Journal of the American Society of Nephrology 	2015	18
25882434	Creatinine	Basu RK	Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study.	BMC nephrology	2015	17
25928556	Creatinine	Kanji T	Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.	BMC nephrology	2015	18
26015453	Creatinine	Schwartzman M	Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.	Journal of the American Society of Nephrology 	2016	10
26038526	Creatinine	Hodgin JB	Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.	Journal of the American Society of Nephrology 	2015	35
26040904	Creatinine	Solé C	miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.	Nephrology, dialysis, transplantation 	2015	25
26139298	Creatinine	Duijvesz D	Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.	International journal of cancer	2015	17
26180129	Creatinine	Peralta CA	APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.	Journal of the American Society of Nephrology 	2016	17
26187471	Creatinine	Kramer H	Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.	American journal of kidney diseases 	2016	13
26342047	Creatinine	Dewitte A	Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery.	Clinical journal of the American Society of Nephrology 	2015	16
26362696	Creatinine	Inker LA	GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.	American journal of kidney diseases 	2016	15
26453610	Creatinine	Hwang YH	Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease.	Journal of the American Society of Nephrology 	2016	13
26566060	Creatinine	Freedman BI	APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.	Transplantation	2016	26
26567246	Creatinine	Seitz-Polski B	Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.	Journal of the American Society of Nephrology 	2016	16
26635076	Creatinine	Unger ED	Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.	European journal of heart failure	2016	11
26690912	Creatinine	Heung M	Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.	American journal of kidney diseases 	2016	11
26837280	Creatinine	Bai X	MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.	Scientific reports	2016	13
26906014	Creatinine	Billings FT 4th	High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.	JAMA	2016	28
26932693	Creatinine	Pottel H	An estimated glomerular filtration rate equation for the full age spectrum.	Nephrology, dialysis, transplantation 	2016	16
26948834	Creatinine	Vijayan A	Clinical Use of the Urine Biomarker TIMP-2 × IGFBP7 for Acute Kidney Injury Risk Assessment.	American journal of kidney diseases 	2016	15
27190381	Creatinine	Ebert N	Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study.	Nephrology, dialysis, transplantation 	2017	6
27451287	Creatinine	Puthumana J	YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation.	Journal of the American Society of Nephrology 	2017	6
27474473	Creatinine	Schrezenmeier EV	Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.	Acta physiologica	2017	8
27479614	Creatinine	Murphy D	Trends in Prevalence of Chronic Kidney Disease in the United States.	Annals of internal medicine	2016	18
27532915	Creatinine	Afkarian M	Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.	JAMA	2016	19
27647855	Creatinine	Voelker J	Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.	Journal of the American Society of Nephrology 	2017	7
27663042	Creatinine	Liu X	Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.	American journal of kidney diseases 	2016	14
27821627	Creatinine	Lafayette RA	A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.	Journal of the American Society of Nephrology 	2017	7
27884474	Creatinine	Ishigami J	CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study.	American journal of kidney diseases 	2017	7
28076311	Creatinine	Kashani K	Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.	Clinical chemistry and laboratory medicine	2017	8
28089986	Creatinine	Pottel H	Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.	Nephrology, dialysis, transplantation 	2017	7
28186566	Creatinine	Menne J	C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.	Nephrology, dialysis, transplantation 	2017	9
28255002	Creatinine	Aubert O	Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.	Journal of the American Society of Nephrology 	2017	5
28262773	Creatinine	Hocher B	Metabolomics for clinical use and research in chronic kidney disease.	Nature reviews. Nephrology	2017	13
12024214	Uric Acid	Enomoto A	Molecular identification of a renal urate anion exchanger that regulates blood urate levels.	Nature	2002	187
12215479	Uric Acid	Watanabe S	Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.	Hypertension	2002	92
17660025	Uric Acid	Chonchol M	Relationship of uric acid with progression of kidney disease.	American journal of kidney diseases 	2007	73
17997608	Uric Acid	Li S	The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.	PLoS genetics	2007	91
18179892	Uric Acid	Wallace C	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	American journal of human genetics	2008	178
18337481	Uric Acid	Weiner DE	Uric acid and incident kidney disease in the community.	Journal of the American Society of Nephrology 	2008	80
18701466	Uric Acid	Anzai N	Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.	The Journal of biological chemistry	2008	60
19303683	Uric Acid	Madero M	Uric acid and long-term outcomes in CKD.	American journal of kidney diseases 	2009	70
19506252	Uric Acid	Woodward OM	Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.	Proceedings of the National Academy of Sciences of the United States of America	2009	120
20884846	Uric Acid	Yang Q	Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.	Circulation. Cardiovascular genetics	2010	100
22028277	Uric Acid	Zoppini G	Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.	Diabetes care	2012	37
23089270	Uric Acid	Bobulescu IA	Renal transport of uric acid: evolving concepts and uncertainties.	Advances in chronic kidney disease	2012	37
24163269	Uric Acid	Mulay SR	Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease.	Nephrology, dialysis, transplantation 	2014	27
24441388	Uric Acid	Matsuo H	ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.	Scientific reports	2014	21
25646370	Uric Acid	Matsuo H	Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.	Annals of the rheumatic diseases	2016	22
26316329	Uric Acid	Maiuolo J	Regulation of uric acid metabolism and excretion.	International journal of cardiology	2016	19
10601129	Angiotensinogen	Rohrwasser A	Elements of a paracrine tubular renin-angiotensin system along the entire nephron.	Hypertension	1999	105
12511528	Angiotensinogen	Kobori H	Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.	Hypertension	2003	97
17878513	Angiotensinogen	Kobori H	The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.	Pharmacological reviews	2007	334
19075095	Angiotensinogen	Kobori H	Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.	Hypertension	2009	65
21339086	Angiotensinogen	Navar LG	Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension.	Current opinion in pharmacology	2011	53
22997258	Angiotensinogen	Nakano D	Multiphoton imaging of the glomerular permeability of angiotensinogen.	Journal of the American Society of Nephrology 	2012	42
23143504	Angiotensinogen	Alge JL	Urinary angiotensinogen and risk of severe AKI.	Clinical journal of the American Society of Nephrology 	2013	26
24694986	Angiotensinogen	Goraya N	Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.	Kidney international	2014	32
16107837	Antiviral Agents	Feld JJ	Mechanism of action of interferon and ribavirin in treatment of hepatitis C.	Nature	2005	240
21447873	Antiviral Agents	Lee N	Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.	Antiviral therapy	2011	35
21808013	Antiviral Agents	Erikson E	In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
22248663	Antiviral Agents	Thomas E	HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.	Gastroenterology	2012	103
23429702	Antiviral Agents	Kim JH	Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.	Science	2013	28
25754160	Antiviral Agents	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	30
14974943	Azathioprine	Opelz G	Lymphomas after solid organ transplantation: a collaborative transplant study report.	American journal of transplantation 	2004	92
24088957	Azathioprine	Sinha A	Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.	Kidney international	2014	24
16150899	Adrenal Cortex Hormones	Snyder PM	Minireview: regulation of epithelial Na+ channel trafficking.	Endocrinology	2005	76
16710025	Adrenal Cortex Hormones	Beck KE	Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.	Journal of clinical oncology 	2006	124
20966123	Adrenal Cortex Hormones	McCarthy ET	Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.	Clinical journal of the American Society of Nephrology 	2010	69
24411715	Adrenal Cortex Hormones	Rovin BH	Lupus nephritis: the evolving role of novel therapeutics.	American journal of kidney diseases 	2014	22
24658533	Adrenal Cortex Hormones	Moriyama T	Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan.	PloS one	2014	21
28303661	Adrenal Cortex Hormones	Iwase H	Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.	Xenotransplantation	2017	9
28323125	Adrenal Cortex Hormones	Urban TJ	Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.	Journal of hepatology	2017	5
11168923	Steroids	Guijarro C	Transcription factor-kappa B (NF-kappa B) and renal disease.	Kidney international	2001	85
19584865	Steroids	Weaver TA	Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.	Nature medicine	2009	77
20382325	Steroids	Hildebrandt F	Genetic kidney diseases.	Lancet	2010	53
21415313	Steroids	Santín S	Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.	Clinical journal of the American Society of Nephrology 	2011	38
21898030	Steroids	Kawano M	Proposal for diagnostic criteria for IgG4-related kidney disease.	Clinical and experimental nephrology	2011	58
21997394	Steroids	Kopp JB	APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.	Journal of the American Society of Nephrology 	2011	194
24429405	Steroids	Sinha A	Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.	Kidney international	2014	22
24509478	Steroids	Tory K	Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome.	Nature genetics	2014	25
25349199	Steroids	Sadowski CE	A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.	Journal of the American Society of Nephrology 	2015	89
25635037	Steroids	Trautmann A	Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.	Clinical journal of the American Society of Nephrology 	2015	33
25961457	Steroids	Gee HY	KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.	The Journal of clinical investigation	2015	36
25967120	Steroids	Korkmaz E	ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.	Journal of the American Society of Nephrology 	2016	12
26346198	Steroids	Gast C	Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis.	Nephrology, dialysis, transplantation 	2016	13
27160407	Steroids	Ville S	Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.	Journal of the American Society of Nephrology 	2016	13
28117080	Steroids	Bierzynska A	Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.	Kidney international	2017	7
1596899	Folic Acid	Weitman SD	Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.	Cancer research	1992	138
17848650	Folic Acid	Jamison RL	Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.	JAMA	2007	94
20571015	Folic Acid	Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group.	Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.	JAMA	2010	60
21568705	Folic Acid	Zhao R	Mechanisms of membrane transport of folates into cells and across epithelia.	Annual review of nutrition	2011	65
26449608	Folic Acid	Craciun FL	RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.	Journal of the American Society of Nephrology 	2016	10
19240154	C-Peptide	Gauglitz GG	Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn.	The Journal of clinical endocrinology and metabolism	2009	56
23413806	C-Peptide	Jones AG	The clinical utility of C-peptide measurement in the care of patients with diabetes.	Diabetic medicine 	2013	52
26242184	C-Peptide	Jones AG	Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.	Diabetes care	2016	11
8692893	Nitric Oxide	Xia Y	Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury.	Proceedings of the National Academy of Sciences of the United States of America	1996	136
8876227	Nitric Oxide	MacMillan-Crow LA	Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts.	Proceedings of the National Academy of Sciences of the United States of America	1996	126
11708836	Nitric Oxide	Bolli R	Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.	Journal of molecular and cellular cardiology	2001	106
12849456	Nitric Oxide	Smith KJ	The role of nitric oxide in multiple sclerosis.	The Lancet. Neurology	2002	90
12925778	Nitric Oxide	Metzen E	Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases.	Molecular biology of the cell	2003	88
14990351	Nitric Oxide	Gladwin MT	The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.	Free radical biology & medicine	2004	76
15284284	Nitric Oxide	Endemann DH	Endothelial dysfunction.	Journal of the American Society of Nephrology 	2004	161
15845500	Nitric Oxide	Zughaier SM	Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.	Infection and immunity	2005	68
16183628	Nitric Oxide	Wilcox CS	Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?	American journal of physiology. Regulatory, integrative and comparative physiology	2005	101
16192427	Nitric Oxide	Amabile N	Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.	Journal of the American Society of Nephrology 	2005	96
16380482	Nitric Oxide	Segal MS	Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.	Diabetes	2006	69
16864653	Nitric Oxide	Fernández-Hernando C	Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase.	The Journal of cell biology	2006	71
17893272	Nitric Oxide	Dejam A	Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation.	Circulation	2007	107
17928410	Nitric Oxide	Baylis C	Nitric oxide deficiency in chronic kidney disease.	American journal of physiology. Renal physiology	2008	91
17933965	Nitric Oxide	Palm F	Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.	American journal of physiology. Heart and circulatory physiology	2007	75
19088044	Nitric Oxide	Kusmartsev S	Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.	Clinical cancer research 	2008	87
19265036	Nitric Oxide	AbouAlaiwi WA	Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades.	Circulation research	2009	86
20613714	Nitric Oxide	Yilmaz MI	FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.	Kidney international	2010	44
21130134	Nitric Oxide	Kular L	The CCN family: a new class of inflammation modulators?	Biochimie	2011	47
21883939	Nitric Oxide	Montezano AC	Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.	Basic & clinical pharmacology & toxicology	2012	43
22170620	Nitric Oxide	Gwathmey TM	Novel roles of nuclear angiotensin receptors and signaling mechanisms.	American journal of physiology. Regulatory, integrative and comparative physiology	2012	43
23130158	Nitric Oxide	Santulli G	CaMK4 Gene Deletion Induces Hypertension.	Journal of the American Heart Association	2012	79
23132368	Nitric Oxide	Bidani AK	Renal microvascular dysfunction, hypertension and CKD progression.	Current opinion in nephrology and hypertension	2013	32
23165403	Nitric Oxide	Agarwal A	Insight into oxidative stress in varicocele-associated male infertility: part 1.	Nature reviews. Urology	2012	38
23306778	Nitric Oxide	Muniyappa R	Role of insulin resistance in endothelial dysfunction.	Reviews in endocrine & metabolic disorders	2013	44
23477738	Nitric Oxide	Speer T	Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.	Immunity	2013	51
24284821	Nitric Oxide	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24918289	Nitric Oxide	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
25398989	Nitric Oxide	Potoka KP	Vasculopathy and pulmonary hypertension in sickle cell disease.	American journal of physiology. Lung cellular and molecular physiology	2015	21
25834230	Nitric Oxide	Carlström M	Renal autoregulation in health and disease.	Physiological reviews	2015	44
26510464	Nitric Oxide	Hawkes MT	Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial.	Malaria journal	2015	21
26712462	Nitric Oxide	Zhang J	Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron.	Cell metabolism	2016	15
26871664	Nitric Oxide	Ince C	THE ENDOTHELIUM IN SEPSIS.	Shock	2016	19
10611961	Phosphatidylinositols	Bamburg JR	Proteins of the ADF/cofilin family: essential regulators of actin dynamics.	Annual review of cell and developmental biology	1999	301
12566441	Phosphatidylinositols	Fujino H	Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases.	The Journal of biological chemistry	2003	77
14528310	Phosphatidylinositols	Rong R	PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis.	Nature neuroscience	2003	96
15284297	Phosphatidylinositols	Sharples EJ	Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.	Journal of the American Society of Nephrology 	2004	82
16446424	Phosphatidylinositols	Furuya F	Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	65
17082479	Phosphatidylinositols	Schefe JH	A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.	Circulation research	2006	63
17170431	Phosphatidylinositols	Shin YK	Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K.	The Journal of general virology	2007	62
18082612	Phosphatidylinositols	Wu H	PDZ domains of Par-3 as potential phosphoinositide signaling integrators.	Molecular cell	2007	66
19050071	Phosphatidylinositols	Sun Q	Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2008	187
19272022	Phosphatidylinositols	Ooms LM	The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.	The Biochemical journal	2009	72
19602587	Phosphatidylinositols	Huang J	Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.	Cancer research	2009	46
20519507	Phosphatidylinositols	He W	Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.	The Journal of biological chemistry	2010	45
23318419	Phosphatidylinositols	Brouxhon SM	Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.	Oncogene	2014	22
27844272	Phosphatidylinositols	Duran I	Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action.	Targeted oncology	2017	7
28154160	Phosphatidylinositols	Badgandi HB	Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins.	The Journal of cell biology	2017	11
15800227	Sirolimus	Stallone G	Sirolimus for Kaposi's sarcoma in renal-transplant recipients.	The New England journal of medicine	2005	146
15899889	Sirolimus	Chiang GG	Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase.	The Journal of biological chemistry	2005	163
16567633	Sirolimus	Shillingford JM	The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	209
16627617	Sirolimus	Yang Q	TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.	Proceedings of the National Academy of Sciences of the United States of America	2006	67
17253963	Sirolimus	Findlay GM	A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling.	The Biochemical journal	2007	100
17595159	Sirolimus	Chan EY	siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy.	The Journal of biological chemistry	2007	147
17671177	Sirolimus	Ma L	Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.	Cancer research	2007	58
18184959	Sirolimus	Bissler JJ	Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.	The New England journal of medicine	2008	296
18403916	Sirolimus	Drummond MJ	Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis.	Current opinion in clinical nutrition and metabolic care	2008	50
18614546	Sirolimus	Rosner M	Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.	Human molecular genetics	2008	75
18653228	Sirolimus	Motzer RJ	Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.	Lancet	2008	689
18722871	Sirolimus	Curatolo P	Tuberous sclerosis.	Lancet	2008	171
18925875	Sirolimus	García-Martínez JM	mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).	The Biochemical journal	2008	311
19306412	Sirolimus	Amato RJ	A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.	Cancer	2009	45
19796751	Sirolimus	Rini BI	Resistance to targeted therapy in renal-cell carcinoma.	The Lancet. Oncology	2009	134
19875810	Sirolimus	Lieberthal W	The role of the mammalian target of rapamycin (mTOR) in renal disease.	Journal of the American Society of Nephrology 	2009	81
20008787	Sirolimus	Kharas MG	Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.	Blood	2010	90
20022946	Sirolimus	Soliman GA	mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.	The Journal of biological chemistry	2010	81
20038814	Sirolimus	Ma J	Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.	The Journal of clinical investigation	2010	76
20075061	Sirolimus	Shillingford JM	Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.	Journal of the American Society of Nephrology 	2010	73
20466742	Sirolimus	Perico N	Sirolimus therapy to halt the progression of ADPKD.	Journal of the American Society of Nephrology 	2010	42
20581392	Sirolimus	Walz G	Everolimus in patients with autosomal dominant polycystic kidney disease.	The New England journal of medicine	2010	134
20805416	Sirolimus	Haidinger M	A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.	Journal of immunology	2010	63
21346035	Sirolimus	Finley DS	Tumor biology and prognostic factors in renal cell carcinoma.	The oncologist	2011	39
21413931	Sirolimus	Pearce LR	Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.	The Biochemical journal	2011	53
21915260	Sirolimus	Dabora SL	Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.	PloS one	2011	48
22125056	Sirolimus	Weichhart T	Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life.	Methods in molecular biology	2012	36
22193387	Sirolimus	Cinà DP	Inhibition of MTOR disrupts autophagic flux in podocytes.	Journal of the American Society of Nephrology 	2012	39
22397650	Sirolimus	Gerlinger M	Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.	The New England journal of medicine	2012	1714
22773827	Sirolimus	Fukuda A	Growth-dependent podocyte failure causes glomerulosclerosis.	Journal of the American Society of Nephrology 	2012	43
22994804	Sirolimus	Akimova T	Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.	American journal of transplantation 	2012	32
23173671	Sirolimus	Cui L	MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.	BMC cancer	2012	31
24056770	Sirolimus	Canaud G	AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.	Nature medicine	2013	46
24092929	Sirolimus	Yamahara K	Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.	Journal of the American Society of Nephrology 	2013	43
24631838	Sirolimus	Grabiner BC	A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.	Cancer discovery	2014	83
24841777	Sirolimus	Albiges L	A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.	European urology	2015	30
24931163	Sirolimus	Dodd KM	mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.	Oncogene	2015	24
25224527	Sirolimus	Kumari D	Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.	Human mutation	2014	21
25444920	Sirolimus	Zheng B	Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.	Cancer letters	2015	21
26156073	Sirolimus	Bissler JJ	Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.	Nephrology, dialysis, transplantation 	2016	28
26364551	Sirolimus	Powles T	A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.	European urology	2016	13
26927950	Sirolimus	Curatolo P	The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.	Drugs	2016	11
27226234	Sirolimus	Henske EP	Tuberous sclerosis complex.	Nature reviews. Disease primers	2016	22
8962164	Antioxidants	Venugopal R	Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.	Proceedings of the National Academy of Sciences of the United States of America	1996	246
10385606	Antioxidants	Brigelius-Flohé R	Vitamin E: function and metabolism.	FASEB journal 	1999	154
10569628	Antioxidants	Brigelius-Flohé R	Tissue-specific functions of individual glutathione peroxidases.	Free radical biology & medicine	1999	132
12372842	Antioxidants	Evans JL	Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.	Endocrine reviews	2002	325
17916769	Antioxidants	Sukhanov S	IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	64
18227481	Antioxidants	Paravicini TM	NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.	Diabetes care	2008	159
19248856	Antioxidants	Holt EM	Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents.	Journal of the American Dietetic Association	2009	55
20939814	Antioxidants	Kashihara N	Oxidative stress in diabetic nephropathy.	Current medicinal chemistry	2010	68
22014576	Antioxidants	Ooi A	An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.	Cancer cell	2011	95
22014577	Antioxidants	Adam J	Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.	Cancer cell	2011	127
24191240	Antioxidants	Trujillo J	Renoprotective effect of the antioxidant curcumin: Recent findings.	Redox biology	2013	41
25140450	Antioxidants	Choi BH	Effect of redox modulating NRF2 activators on chronic kidney disease.	Molecules	2014	21
26335400	Antioxidants	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
14592543	Anti-Inflammatory Agents, Non-Steroidal	Vane JR	The mechanism of action of aspirin.	Thrombosis research	2003	120
15117884	Anti-Inflammatory Agents, Non-Steroidal	Warner TD	Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.	FASEB journal 	2004	103
16395396	Anti-Inflammatory Agents, Non-Steroidal	Grosser T	Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.	The Journal of clinical investigation	2006	194
19203472	Anti-Inflammatory Agents, Non-Steroidal	Rao P	Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.	Journal of pharmacy & pharmaceutical sciences 	2008	70
25862494	Anti-Inflammatory Agents, Non-Steroidal	Ungprasert P	Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.	European journal of internal medicine	2015	19
25874600	Anti-Inflammatory Agents, Non-Steroidal	Dreischulte T	Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.	Kidney international	2015	15
21903574	Homocysteine	Kendrick J	FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.	Journal of the American Society of Nephrology 	2011	129
22626821	Homocysteine	Duranton F	Normal and pathologic concentrations of uremic toxins.	Journal of the American Society of Nephrology 	2012	94
27289364	Homocysteine	Beck BB	Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.	Pediatric nephrology	2017	6
15149314	Cyclosporine	Schrijvers BF	The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.	Kidney international	2004	96
15326303	Cyclosporine	Nisole S	A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.	Proceedings of the National Academy of Sciences of the United States of America	2004	154
16434506	Cyclosporine	Campistol JM	Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.	Journal of the American Society of Nephrology 	2006	61
17072346	Cyclosporine	Tarze A	GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization.	Oncogene	2007	67
20415897	Cyclosporine	Vincenti F	A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).	American journal of transplantation 	2010	163
20415898	Cyclosporine	Durrbach A	A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).	American journal of transplantation 	2010	74
21334736	Cyclosporine	Budde K	Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.	Lancet	2011	46
21992533	Cyclosporine	Vincenti F	Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.	American journal of transplantation 	2012	50
24047110	Cyclosporine	Rostaing L	Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study.	American journal of transplantation 	2013	36
26047793	Cyclosporine	Guidicelli G	Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.	Journal of the American Society of Nephrology 	2016	16
15782185	Adenosine	Hoffmann C	A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.	Nature methods	2005	114
16816141	Adenosine	Vallon V	Adenosine and kidney function.	Physiological reviews	2006	87
17908822	Adenosine	Paz N	Altered adenosine-to-inosine RNA editing in human cancer.	Genome research	2007	95
20977632	Adenosine	Dwyer KM	Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.	American journal of transplantation 	2010	59
22559880	Adenosine	Tosh DK	Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo3.1.0hexane substitutions.	Journal of medicinal chemistry	2012	38
24552285	Adenosine	Navon Elkan P	Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.	The New England journal of medicine	2014	38
27780585	Adenosine	Menzies RI	Purinergic signaling in kidney disease.	Kidney international	2017	11
10371508	Tacrolimus	Kirk AD	Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.	Nature medicine	1999	101
15707414	Tacrolimus	Brennan DC	Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.	American journal of transplantation 	2005	87
19218475	Tacrolimus	Naesens M	Calcineurin inhibitor nephrotoxicity.	Clinical journal of the American Society of Nephrology 	2009	138
19563339	Tacrolimus	Ekberg H	Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.	American journal of transplantation 	2009	46
19732725	Tacrolimus	Pei H	FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.	Cancer cell	2009	184
20393454	Tacrolimus	Thervet E	Optimization of initial tacrolimus dose using pharmacogenetic testing.	Clinical pharmacology and therapeutics	2010	55
20813870	Tacrolimus	Park WD	Fibrosis with inflammation at one year predicts transplant functional decline.	Journal of the American Society of Nephrology 	2010	45
21804023	Tacrolimus	Hutchinson JA	Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.	Journal of immunology	2011	48
23137180	Tacrolimus	Hirsch HH	Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.	American journal of transplantation 	2013	28
24249597	Tacrolimus	Hesselink DA	The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.	Clinical pharmacokinetics	2014	33
25925687	Tacrolimus	Hricik DE	Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.	Journal of the American Society of Nephrology 	2015	21
26639422	Tacrolimus	Hirsch HH	BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.	American journal of transplantation 	2016	11
26667830	Tacrolimus	Sanghavi K	Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.	The pharmacogenomics journal	2017	6
12874436	Reactive Oxygen Species	Inoguchi T	Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.	Journal of the American Society of Nephrology 	2003	80
16765337	Reactive Oxygen Species	Paravicini TM	Redox signaling in hypertension.	Cardiovascular research	2006	120
17184177	Reactive Oxygen Species	Nishikawa T	Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications.	Antioxidants & redox signaling	2007	83
17687073	Reactive Oxygen Species	Sachse A	Angiotensin II-induced reactive oxygen species and the kidney.	Journal of the American Society of Nephrology 	2007	70
18485895	Reactive Oxygen Species	Hasegawa K	Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression.	Biochemical and biophysical research communications	2008	56
19059306	Reactive Oxygen Species	Garrido AM	NADPH oxidases and angiotensin II receptor signaling.	Molecular and cellular endocrinology	2009	99
19236887	Reactive Oxygen Species	Liu J	Role of oxidative stress in cadmium toxicity and carcinogenesis.	Toxicology and applied pharmacology	2009	71
19706525	Reactive Oxygen Species	Block K	Subcellular localization of Nox4 and regulation in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
20942471	Reactive Oxygen Species	Laleu B	First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.	Journal of medicinal chemistry	2010	75
20981034	Reactive Oxygen Species	Touyz RM	Reactive oxygen species and vascular biology: implications in human hypertension.	Hypertension research 	2011	86
21232014	Reactive Oxygen Species	Wu S	Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins.	The FEBS journal	2011	82
21307839	Reactive Oxygen Species	Barnes JL	Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.	Kidney international	2011	108
21371295	Reactive Oxygen Species	Pujalté I	Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells.	Particle and fibre toxicology	2011	45
22530599	Reactive Oxygen Species	Nguyen Dinh Cat A	Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.	Antioxidants & redox signaling	2013	55
22713144	Reactive Oxygen Species	Montezano AC	Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.	Annals of medicine	2012	42
23472618	Reactive Oxygen Species	Araujo M	Oxidative stress in hypertension: role of the kidney.	Antioxidants & redox signaling	2014	31
23472786	Reactive Oxygen Species	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
23767990	Reactive Oxygen Species	Gorin Y	Nox as a target for diabetic complications.	Clinical science	2013	30
23970124	Reactive Oxygen Species	Sedeek M	NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.	Journal of the American Society of Nephrology 	2013	48
24511132	Reactive Oxygen Species	Jha JC	Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	51
25406339	Reactive Oxygen Species	Kawakami T	Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.	Journal of the American Society of Nephrology 	2015	27
25767287	Reactive Oxygen Species	McMaster WG	Inflammation, immunity, and hypertensive end-organ damage.	Circulation research	2015	83
27127546	Reactive Oxygen Species	Minutoli L	ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.	Oxidative medicine and cellular longevity	2016	17
20056746	Formaldehyde	Krupa A	Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	108
20710042	Formaldehyde	Aleksic T	Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.	Cancer research	2010	60
24242678	Formaldehyde	Heinzelmann J	MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.	Annals of surgical oncology	2014	21
24357669	Formaldehyde	Venkatareddy M	Estimating podocyte number and density using a single histologic section.	Journal of the American Society of Nephrology 	2014	34
15452403	Calcitriol	González EA	Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.	American journal of nephrology	2004	75
15531762	Calcitriol	Saito H	Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.	The Journal of biological chemistry	2005	93
15613425	Calcitriol	Ferrari SL	Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.	The Journal of clinical endocrinology and metabolism	2005	104
15618484	Calcitriol	Hoenderop JG	Calcium absorption across epithelia.	Physiological reviews	2005	122
15917335	Calcitriol	Gutierrez O	Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.	Journal of the American Society of Nephrology 	2005	204
18299495	Calcitriol	Kovesdy CP	Association of activated vitamin D treatment and mortality in chronic kidney disease.	Archives of internal medicine	2008	62
18463168	Calcitriol	Shoben AB	Association of oral calcitriol with improved survival in nondialyzed CKD.	Journal of the American Society of Nephrology 	2008	58
20007751	Calcitriol	Stubbs JR	Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.	Journal of the American Society of Nephrology 	2010	40
20507943	Calcitriol	Wolf M	Forging forward with 10 burning questions on FGF23 in kidney disease.	Journal of the American Society of Nephrology 	2010	71
11430844	Adrenocorticotropic Hormone	Heim C	The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.	Biological psychiatry	2001	488
10419473	Cholecalciferol	Nishiyama A	Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression.	The Journal of biological chemistry	1999	152
18088161	Cholecalciferol	Cranney A	Effectiveness and safety of vitamin D in relation to bone health.	Evidence report/technology assessment	2007	113
18689389	Cholecalciferol	Norman AW	From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health.	The American journal of clinical nutrition	2008	126
20427749	Cholecalciferol	Burton JM	A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.	Neurology	2010	66
21311504	Cholecalciferol	Harris RA	Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults.	American journal of hypertension	2011	43
1944469	Cyclic AMP	Weinstein LS	Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.	The New England journal of medicine	1991	221
12552097	Cyclic AMP	Baillie GS	beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.	Proceedings of the National Academy of Sciences of the United States of America	2003	112
12753285	Cyclic AMP	Yamaguchi T	Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.	Kidney international	2003	96
16928806	Cyclic AMP	Smith LA	Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.	Journal of the American Society of Nephrology 	2006	63
17088426	Cyclic AMP	Terrin A	PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different cAMP: role of compartmentalized phosphodiesterases.	The Journal of cell biology	2006	75
17565987	Cyclic AMP	Zhang F	Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.	The Journal of biological chemistry	2007	67
17591856	Cyclic AMP	Kim HP	CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.	The Journal of experimental medicine	2007	192
17877633	Cyclic AMP	Kroslak T	The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.	Journal of neurochemistry	2007	72
19701185	Cyclic AMP	Ferrandon S	Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.	Nature chemical biology	2009	132
20181668	Cyclic AMP	Hallows KR	Role of the energy sensor AMP-activated protein kinase in renal physiology and disease.	American journal of physiology. Renal physiology	2010	43
21103974	Cyclic AMP	Keppler D	Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.	Handbook of experimental pharmacology	2011	55
21118718	Cyclic AMP	Wallace DP	Cyclic AMP-mediated cyst expansion.	Biochimica et biophysica acta	2011	43
21354433	Cyclic AMP	Cheng SB	Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus.	Steroids	2011	40
22108457	Cyclic AMP	Hoffert JD	Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics.	Molecular & cellular proteomics 	2012	32
22977732	Cyclic AMP	Nookala RK	Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer.	Open biology	2012	35
23935101	Cyclic AMP	Feinstein TN	Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin.	The Journal of biological chemistry	2013	42
15781736	Natriuretic Peptide, Brain	Sackner-Bernstein JD	Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.	Circulation	2005	95
18154959	Natriuretic Peptide, Brain	Daniels LB	Natriuretic peptides.	Journal of the American College of Cardiology	2007	143
21733911	Natriuretic Peptide, Brain	Seiler S	The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.	European heart journal	2011	38
21791540	Natriuretic Peptide, Brain	Maisel AS	Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.	European journal of heart failure	2011	44
22026577	Natriuretic Peptide, Brain	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22431676	Natriuretic Peptide, Brain	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22437503	Atrial Natriuretic Factor	Cui Y	Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy.	Nature	2012	43
19332353	Antihypertensive Agents	Krum H	Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.	Lancet	2009	275
19846849	Antihypertensive Agents	ESCAPE Trial Group.	Strict blood-pressure control and progression of renal failure in children.	The New England journal of medicine	2009	111
20445497	Antihypertensive Agents	Mahajan A	Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.	Kidney international	2010	63
21093036	Antihypertensive Agents	Symplicity HTN-2 Investigators.	Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.	Lancet	2010	272
22445098	Antihypertensive Agents	Montezano AC	Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.	The Canadian journal of cardiology	2012	44
24210779	Antihypertensive Agents	Krum H	Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.	Lancet	2014	80
12808161	Acetylcysteine	Locatelli F	Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.	Nephrology, dialysis, transplantation 	2003	93
17142801	Acetylcysteine	Leonard MO	Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.	FASEB journal 	2006	60
22202674	Acetylcysteine	Zhang H	Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.	FASEB journal 	2012	34
24225429	8-oxo-7-hydrodeoxyguanosine	Fujita H	DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy.	Endocrine journal	2014	25
28043842	8-oxo-7-hydrodeoxyguanosine	Ferguson KK	Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.	American journal of obstetrics and gynecology	2017	9
15707400	Immunosuppressive Agents	Pearl JP	Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.	American journal of transplantation 	2005	114
16613591	Immunosuppressive Agents	Meier-Kriesche HU	Immunosuppression: evolution in practice and trends, 1994-2004.	American journal of transplantation 	2006	69
20170205	Immunosuppressive Agents	Staatz CE	Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.	Clinical pharmacokinetics	2010	51
21903774	Immunosuppressive Agents	Elens L	A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.	Clinical chemistry	2011	43
17093248	Antilymphocyte Serum	Brennan DC	Rabbit antithymocyte globulin versus basiliximab in renal transplantation.	The New England journal of medicine	2006	82
20883548	Antilymphocyte Serum	Gurkan S	Immune reconstitution following rabbit antithymocyte globulin.	American journal of transplantation 	2010	55
22405058	Antilymphocyte Serum	Scandling JD	Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.	American journal of transplantation 	2012	54
9074572	Angiotensin-Converting Enzyme Inhibitors	Pitt B	Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)	Lancet	1997	110
9217756	Angiotensin-Converting Enzyme Inhibitors	-	Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)	Lancet	1997	162
10924499	Angiotensin-Converting Enzyme Inhibitors	Tipnis SR	A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.	The Journal of biological chemistry	2000	207
11181474	Angiotensin-Converting Enzyme Inhibitors	Guerin AP	Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.	Circulation	2001	118
11453706	Angiotensin-Converting Enzyme Inhibitors	Jafar TH	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.	Annals of internal medicine	2001	106
12965979	Angiotensin-Converting Enzyme Inhibitors	Jafar TH	Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.	Annals of internal medicine	2003	137
14769700	Angiotensin-Converting Enzyme Inhibitors	McAlister FA	Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.	Circulation	2004	97
15766995	Angiotensin-Converting Enzyme Inhibitors	Ruggenenti P	Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.	Lancet	2005	87
16338452	Angiotensin-Converting Enzyme Inhibitors	Casas JP	Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.	Lancet	2005	82
17984482	Angiotensin-Converting Enzyme Inhibitors	Kunz R	Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.	Annals of internal medicine	2008	98
17984484	Angiotensin-Converting Enzyme Inhibitors	Matchar DB	Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.	Annals of internal medicine	2008	64
19643310	Angiotensin-Converting Enzyme Inhibitors	Edwards NC	Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.	Journal of the American College of Cardiology	2009	50
21734090	Angiotensin-Converting Enzyme Inhibitors	Plataki M	Predictors of acute kidney injury in septic shock patients: an observational cohort study.	Clinical journal of the American Society of Nephrology 	2011	36
22135311	Angiotensin-Converting Enzyme Inhibitors	Vegter S	Sodium intake, ACE inhibition, and progression to ESRD.	Journal of the American Society of Nephrology 	2012	43
22166847	Angiotensin-Converting Enzyme Inhibitors	Gross O	Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.	Kidney international	2012	39
22189484	Angiotensin-Converting Enzyme Inhibitors	Vejakama P	Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.	Diabetologia	2012	32
23100218	Angiotensin-Converting Enzyme Inhibitors	Ruggenenti P	Mechanisms and treatment of CKD.	Journal of the American Society of Nephrology 	2012	41
24157497	Angiotensin-Converting Enzyme Inhibitors	Wu HY	Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.	BMJ	2013	32
24206457	Angiotensin-Converting Enzyme Inhibitors	Fried LF	Combined angiotensin inhibition for the treatment of diabetic nephropathy.	The New England journal of medicine	2013	121
24343093	Angiotensin-Converting Enzyme Inhibitors	Hsu TW	Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.	JAMA internal medicine	2014	33
26009228	Angiotensin-Converting Enzyme Inhibitors	Palmer SC	Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.	Lancet	2015	37
26076923	Angiotensin-Converting Enzyme Inhibitors	Wang X	CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.	The pharmacogenomics journal	2016	11
26597926	Angiotensin-Converting Enzyme Inhibitors	Xie X	Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.	American journal of kidney diseases 	2016	12
16860976	Hypoglycemic Agents	Vuksan V	Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.	Nutrition, metabolism, and cardiovascular diseases 	2008	52
17609683	Hypoglycemic Agents	Shu Y	Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.	Clinical pharmacology and therapeutics	2008	98
21955459	Hypoglycemic Agents	DeFronzo RA	The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.	Diabetes, obesity & metabolism	2012	83
22310849	Hypoglycemic Agents	Ferrannini E	SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.	Nature reviews. Endocrinology	2012	49
26078479	Hypoglycemic Agents	Peters AL	Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	62
26086329	Hypoglycemic Agents	Taylor SI	SGLT2 Inhibitors May Predispose to Ketoacidosis.	The Journal of clinical endocrinology and metabolism	2015	51
27470878	Hypoglycemic Agents	Heerspink HJ	Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.	Circulation	2016	35
1463530	Enalapril	SOLVD Investigators.	Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.	The New England journal of medicine	1992	243
25771069	Enalapril	Huo Y	Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.	JAMA	2015	81
17701281	Allopurinol	Kanbay M	Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.	International urology and nephrology	2007	73
20538833	Allopurinol	Goicoechea M	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.	Clinical journal of the American Society of Nephrology 	2010	136
24042021	Allopurinol	Bose B	Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.	Nephrology, dialysis, transplantation 	2014	36
25115449	Allopurinol	Chung WH	Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.	Annals of the rheumatic diseases	2015	25
25595565	Allopurinol	Goicoechea M	Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.	American journal of kidney diseases 	2015	38
27339448	Allopurinol	Kumagai T	Time to target uric acid to retard CKD progression.	Clinical and experimental nephrology	2017	5
15176987	collagen type I trimeric cross-linked peptide	Bekker PJ	A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.	Journal of bone and mineral research 	2004	114
15342807	collagen type I trimeric cross-linked peptide	Welt CK	Recombinant human leptin in women with hypothalamic amenorrhea.	The New England journal of medicine	2004	174
17785705	collagen type I trimeric cross-linked peptide	Lipton A	Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.	Journal of clinical oncology 	2007	69
19088165	collagen type I trimeric cross-linked peptide	Pittas AG	Association between serum osteocalcin and markers of metabolic phenotype.	The Journal of clinical endocrinology and metabolism	2009	90
19237632	collagen type I trimeric cross-linked peptide	Fizazi K	Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.	Journal of clinical oncology 	2009	108
25022529	Arginine Vasopressin	Grantham JJ	Rationale for early treatment of polycystic kidney disease.	Pediatric nephrology	2015	16
26077742	Arginine Vasopressin	Bockenhauer D	Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.	Nature reviews. Nephrology	2015	17
9890309	podocalyxin	Barisoni L	The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.	Journal of the American Society of Nephrology 	1999	124
10027397	podocalyxin	Breiteneder-Geleff S	Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.	The American journal of pathology	1999	179
11435469	podocalyxin	Doyonnas R	Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin.	The Journal of experimental medicine	2001	89
17229675	podocalyxin	Cheruvanky A	Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.	American journal of physiology. Renal physiology	2007	57
19578008	podocalyxin	Nielsen JS	The role of podocalyxin in health and disease.	Journal of the American Society of Nephrology 	2009	47
20686450	podocalyxin	Rood IM	Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome.	Kidney international	2010	52
26493500	podocalyxin	Freedman BS	Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.	Nature communications	2015	48
23022011	Calcium Oxalate	Khan SR	Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.	The Journal of urology	2013	37
26817517	Calcium Oxalate	Mulay SR	Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.	Nature communications	2016	23
17088055	bisphenol A	Thomas P	Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.	The Journal of steroid biochemistry and molecular biology	2006	127
19433248	bisphenol A	Rubin BS	Bisphenol A: Perinatal exposure and body weight.	Molecular and cellular endocrinology	2009	64
19479022	bisphenol A	Stahlhut RW	Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both.	Environmental health perspectives	2009	100
19729343	bisphenol A	Becker K	GerES IV: phthalate metabolites and bisphenol A in urine of German children.	International journal of hygiene and environmental health	2009	45
22046388	bisphenol A	Silver MK	Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008.	PloS one	2011	41
22090277	bisphenol A	Wang T	Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance.	The Journal of clinical endocrinology and metabolism	2012	52
22381621	bisphenol A	Hanna CW	DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF.	Human reproduction	2012	38
23932849	bisphenol A	Lassen TH	Temporal variability in urinary excretion of bisphenol A and seven other phenols in spot, morning, and 24-h urine samples.	Environmental research	2013	26
25385582	bisphenol A	Kundakovic M	DNA methylation of BDNF as a biomarker of early-life adversity.	Proceedings of the National Academy of Sciences of the United States of America	2015	52
26821262	bisphenol A	Vafeiadi M	Association of early life exposure to bisphenol A with obesity and cardiometabolic traits in childhood.	Environmental research	2016	14
27717745	bisphenol A	Morgan M	Environmental estrogen-like endocrine disrupting chemicals and breast cancer.	Molecular and cellular endocrinology	2017	6
9554605	Arsenic	Smith AH	Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.	American journal of epidemiology	1998	122
15526190	Arsenic	Hayakawa T	A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.	Archives of toxicology	2005	68
19037006	Arsenic	Rahman A	Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh.	American journal of epidemiology	2009	73
19167470	Arsenic	Raqib R	Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh.	Toxicology letters	2009	58
20940111	Arsenic	Ahmed S	Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood.	Environmental health perspectives	2011	56
21247820	Arsenic	Engström K	Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism.	Environmental health perspectives	2011	49
21321970	Arsenic	Jomova K	Arsenic: toxicity, oxidative stress and human disease.	Journal of applied toxicology 	2011	92
22466225	Arsenic	Kile ML	Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes.	Environmental health perspectives	2012	54
22713597	Arsenic	Ahmed S	In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis.	Toxicological sciences 	2012	31
23665672	Arsenic	Chen Y	A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh.	Environmental health perspectives	2013	39
23757598	Arsenic	Koestler DC	Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero.	Environmental health perspectives	2013	71
25739736	Arsenic	Schlebusch CM	Human adaptation to arsenic-rich environments.	Molecular biology and evolution	2015	21
26771251	Arsenic	Green BB	Epigenome-Wide Assessment of DNA Methylation in the Placenta and Arsenic Exposure in the New Hampshire Birth Cohort Study (USA).	Environmental health perspectives	2016	13
19221000	decitabine	Majid S	BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.	Carcinogenesis	2009	60
22237753	decitabine	Sun CY	Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.	Kidney international	2012	35
9560283	1,25-dihydroxyvitamin D	Beck L	Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.	Proceedings of the National Academy of Sciences of the United States of America	1998	117
12520530	1,25-dihydroxyvitamin D	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
14733920	1,25-dihydroxyvitamin D	Shimada T	FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.	Biochemical and biophysical research communications	2004	88
16563471	1,25-dihydroxyvitamin D	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	173
17063170	1,25-dihydroxyvitamin D	Nishida Y	Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.	Kidney international	2006	62
17205962	1,25-dihydroxyvitamin D	Craver L	Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.	Nephrology, dialysis, transplantation 	2007	55
19443637	1,25-dihydroxyvitamin D	de Boer IH	25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.	Journal of the American Society of Nephrology 	2009	69
20515678	1,25-dihydroxyvitamin D	Tomaschitz A	Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.	Clinica chimica acta; international journal of clinical chemistry	2010	49
21030580	1,25-dihydroxyvitamin D	Vervloet MG	Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.	Clinical journal of the American Society of Nephrology 	2011	47
21845364	1,25-dihydroxyvitamin D	White JH	Vitamin D metabolism and signaling in the immune system.	Reviews in endocrine & metabolic disorders	2012	42
21982773	1,25-dihydroxyvitamin D	Forster RE	Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells.	Biochemical and biophysical research communications	2011	38
22249518	1,25-dihydroxyvitamin D	Quarles LD	Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.	Nature reviews. Endocrinology	2012	50
22398410	1,25-dihydroxyvitamin D	Bhan I	Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.	Kidney international	2012	61
22446158	1,25-dihydroxyvitamin D	Adams JS	Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.	Archives of biochemistry and biophysics	2012	56
22886720	1,25-dihydroxyvitamin D	Bacchetta J	Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.	Journal of bone and mineral research 	2013	31
23423976	1,25-dihydroxyvitamin D	Jacobs ET	CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.	Cancer research	2013	28
23431388	1,25-dihydroxyvitamin D	Kitagawa M	A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.	PloS one	2013	37
24569459	1,25-dihydroxyvitamin D	Carpenter TO	Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.	The Journal of clinical investigation	2014	34
24690624	1,25-dihydroxyvitamin D	Theodoratou E	Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials.	BMJ	2014	119
27535551	1,25-dihydroxyvitamin D	Nguyen-Yamamoto L	Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.	Journal of the American Society of Nephrology 	2017	6
28409320	1,25-dihydroxyvitamin D	Garbossa SG	Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.	Reviews in endocrine & metabolic disorders	2017	6
21103968	estrone sulfate	Burckhardt G	In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.	Handbook of experimental pharmacology	2011	38
9874808	11-dehydro-thromboxane B2	McAdam BF	Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.	Proceedings of the National Academy of Sciences of the United States of America	1999	173
12387653	11-dehydro-thromboxane B2	Davì G	Platelet activation in obese women: role of inflammation and oxidant stress.	JAMA	2002	83
11773611	20-hydroxy-5,8,11,14-eicosatetraenoic acid	Roman RJ	P-450 metabolites of arachidonic acid in the control of cardiovascular function.	Physiological reviews	2002	329
16258232	20-hydroxy-5,8,11,14-eicosatetraenoic acid	Miyata N	Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.	Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi	2005	74
18391101	20-hydroxy-5,8,11,14-eicosatetraenoic acid	Ward NC	A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.	Hypertension	2008	50
23584425	20-hydroxy-5,8,11,14-eicosatetraenoic acid	Wu CC	20-HETE and blood pressure regulation: clinical implications.	Cardiology in review	2014	37
25427230	20-hydroxy-5,8,11,14-eicosatetraenoic acid	Fan F	Cytochrome P450 eicosanoids in hypertension and renal disease.	Current opinion in nephrology and hypertension	2015	21
15811980	pro-brain natriuretic peptide (1-76)	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
20659949	pro-brain natriuretic peptide (1-76)	Damman K	Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.	Heart	2010	47
23733199	pro-brain natriuretic peptide (1-76)	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
25414155	pro-brain natriuretic peptide (1-76)	Lovshin JA	Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.	Diabetes care	2015	18
17620607	aristolochic acid I	Grollman AP	Aristolochic acid and the etiology of endemic (Balkan) nephropathy.	Proceedings of the National Academy of Sciences of the United States of America	2007	100
22071594	aristolochic acid I	Jelaković B	Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.	Kidney international	2012	35
22121226	aristolochic acid I	Sidorenko VS	Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts.	Nucleic acids research	2012	32
22493262	aristolochic acid I	Chen CH	Aristolochic acid-associated urothelial cancer in Taiwan.	Proceedings of the National Academy of Sciences of the United States of America	2012	69
23238808	aristolochic acid I	Grollman AP	Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.	Environmental and molecular mutagenesis	2013	30
24921086	aristolochic acid I	Schmeiser HH	Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.	International journal of cancer	2014	21
11439963	globotriaosylceramide	Eng CM	Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.	The New England journal of medicine	2001	192
15154115	globotriaosylceramide	Wilcox WR	Long-term safety and efficacy of enzyme replacement therapy for Fabry disease.	American journal of human genetics	2004	70
17409312	globotriaosylceramide	Germain DP	Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.	Journal of the American Society of Nephrology 	2007	79
20000589	Indican	Schroeder JC	The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.	Biochemistry	2010	55
23325087	Indican	Watanabe H	p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.	Kidney international	2013	35
26209659	Indican	Weber D	Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.	Blood	2015	26
16336578	Mineralocorticoid Receptor Antagonists	Remuzzi G	The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.	Kidney international. Supplement	2005	76
19926893	Mineralocorticoid Receptor Antagonists	Mehdi UF	Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.	Journal of the American Society of Nephrology 	2009	72
20440277	Mineralocorticoid Receptor Antagonists	Ruggenenti P	The RAAS in the pathogenesis and treatment of diabetic nephropathy.	Nature reviews. Nephrology	2010	47
25767291	Mineralocorticoid Receptor Antagonists	Oparil S	New approaches in the treatment of hypertension.	Circulation research	2015	21
16316359	paricalcitol	Agarwal R	Antiproteinuric effect of oral paricalcitol in chronic kidney disease.	Kidney international	2005	91
16820797	paricalcitol	Kalantar-Zadeh K	Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.	Kidney international	2006	190
18525004	paricalcitol	Tan X	Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.	Journal of the American Society of Nephrology 	2008	66
18606901	paricalcitol	Alborzi P	Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial.	Hypertension	2008	94
20203163	paricalcitol	Matias PJ	Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.	Clinical journal of the American Society of Nephrology 	2010	45
21148030	paricalcitol	Raggi P	The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.	Nephrology, dialysis, transplantation 	2011	69
22095947	paricalcitol	He W	Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.	Journal of the American Society of Nephrology 	2012	45
22169009	paricalcitol	Sanchez-Niño MD	Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.	American journal of physiology. Renal physiology	2012	38
22337679	paricalcitol	Thadhani R	Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.	JAMA	2012	97
20847235	alpha-hydroxyglutarate	Kranendijk M	IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.	Science	2010	48
25182153	alpha-hydroxyglutarate	Shim EH	L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.	Cancer discovery	2014	45
23945155	Hematinics	Cooke KS	A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates.	Blood	2013	28
23121377	tolvaptan	Torres VE	Tolvaptan in patients with autosomal dominant polycystic kidney disease.	The New England journal of medicine	2012	217
26908832	tolvaptan	Gansevoort RT	Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.	Nephrology, dialysis, transplantation 	2016	24
26912543	tolvaptan	Torres VE	Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.	Clinical journal of the American Society of Nephrology 	2016	13
16341243	temsirolimus	Thomas GV	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	Nature medicine	2006	169
17158546	temsirolimus	Motzer RJ	Targeted therapy for metastatic renal cell carcinoma.	Journal of clinical oncology 	2006	67
19229667	temsirolimus	Dutcher JP	Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.	Medical oncology	2009	57
21346036	temsirolimus	Hutson TE	Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence.	The oncologist	2011	48
21952069	temsirolimus	Coppin C	Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.	BJU international	2011	55
22891270	temsirolimus	Armstrong AJ	Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.	Journal of clinical oncology 	2012	39
23633458	temsirolimus	von Roemeling CA	Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.	Clinical cancer research 	2013	49
24297945	temsirolimus	Rini BI	Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.	Journal of clinical oncology 	2014	34
21508635	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Pergola PE	Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD.	American journal of nephrology	2011	64
22634319	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Hong DS	A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas.	Clinical cancer research 	2012	44
22966038	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Liby KT	Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.	Pharmacological reviews	2012	75
23325084	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Ruiz S	Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.	Kidney international	2013	78
23783243	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Shelton LM	Role of Nrf2 in protection against acute kidney injury.	Kidney international	2013	28
24206459	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	de Zeeuw D	Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.	The New England journal of medicine	2013	134
24903467	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Chin MP	Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.	American journal of nephrology	2014	26
25364233	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	Wang YY	Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.	Drug design, development and therapy	2014	24
18525041	aliskiren	Parving HH	Aliskiren combined with losartan in type 2 diabetes and nephropathy.	The New England journal of medicine	2008	183
19145003	aliskiren	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
23121378	aliskiren	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	152
23387299	Alanine	Ohta A	The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.	The Biochemical journal	2013	46
23633921	Alanine	Khan AP	The role of sarcosine metabolism in prostate cancer progression.	Neoplasia	2013	34
24681128	Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
25028718	Alanine	Alessi DR	The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.	Science signaling	2014	34
25873639	Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
9467011	Amino Acids	Marsh DJ	Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.	Human molecular genetics	1998	121
12077142	Amino Acids	Miura S	Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium.	The Journal of biological chemistry	2002	98
12510195	Amino Acids	Hergovich A	Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.	Nature cell biology	2003	102
12739169	Amino Acids	Halestrap AP	The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.	Pflugers Archiv 	2004	170
14718572	Amino Acids	Lemmers C	CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.	Molecular biology of the cell	2004	84
16482215	Amino Acids	Nishitani H	Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.	The EMBO journal	2006	152
17310145	Amino Acids	Li W	A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate.	Nature	2007	102
17643073	Amino Acids	Erlich S	Differential interactions between Beclin 1 and Bcl-2 family members.	Autophagy	2007	72
18199800	Amino Acids	Otto EA	NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis.	Journal of the American Society of Nephrology 	2008	79
18234728	Amino Acids	Toro JR	BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.	Journal of medical genetics	2008	84
18460336	Amino Acids	Gulati P	Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34.	Cell metabolism	2008	131
19234517	Amino Acids	Hartman TR	The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.	Oncogene	2009	62
20023659	Amino Acids	Brown EJ	Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis.	Nature genetics	2010	129
21512002	Amino Acids	Narita M	Spatial coupling of mTOR and autophagy augments secretory phenotypes.	Science	2011	129
21775626	Amino Acids	Ward HH	A conserved signal and GTPase complex are required for the ciliary transport of polycystin-1.	Molecular biology of the cell	2011	44
22574197	Amino Acids	Ögmundsdóttir MH	Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.	PloS one	2012	48
23103253	Amino Acids	Elorza A	HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.	Molecular cell	2012	33
23884885	Amino Acids	Menni C	Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.	Diabetes	2013	58
24550457	Amino Acids	Kratzer JT	Evolutionary history and metabolic insights of ancient mammalian uricases.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
24628464	Amino Acids	Bajaj JS	Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.	Alimentary pharmacology & therapeutics	2014	25
24725411	Amino Acids	Schmick M	KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport.	Cell	2014	33
24808134	Amino Acids	Thomson R	Evolution of the primate trypanolytic factor APOL1.	Proceedings of the National Academy of Sciences of the United States of America	2014	55
26334087	Amino Acids	Schmidt LS	Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.	Nature reviews. Urology	2015	21
26590448	Amino Acids	Ramezani A	Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.	American journal of kidney diseases 	2016	17
26724577	Amino Acids	Bhutia YD	Glutamine transporters in mammalian cells and their functions in physiology and cancer.	Biochimica et biophysica acta	2016	12
26797105	Amino Acids	Pires DE	In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity.	Scientific reports	2016	16
26878238	Amino Acids	Loayza-Puch F	Tumour-specific proline vulnerability uncovered by differential ribosome codon reading.	Nature	2016	21
27240091	Amino Acids	Li B	Landscape of tumor-infiltrating T cell repertoire of human cancers.	Nature genetics	2016	26
27302165	Amino Acids	Cormerais Y	Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth.	Cancer research	2016	13
28003482	Amino Acids	Nogales A	NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses.	Journal of virology	2017	6
28089725	Amino Acids	Zhenyukh O	High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.	Free radical biology & medicine	2017	7
28343144	Amino Acids	Chen DQ	Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.	Redox biology	2017	5
17016424	sorafenib	Wilhelm S	Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.	Nature reviews. Drug discovery	2006	298
18165647	sorafenib	Choueiri TK	Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.	Journal of clinical oncology 	2008	89
18219225	sorafenib	Flaherty KT	Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma.	Cancer biology & therapy	2008	50
19064974	sorafenib	Golshayan AR	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.	Journal of clinical oncology 	2009	51
19171708	sorafenib	Escudier B	Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.	Journal of clinical oncology 	2009	105
19451442	sorafenib	Escudier B	Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.	Journal of clinical oncology 	2009	222
19652060	sorafenib	Rini BI	Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.	Journal of clinical oncology 	2009	82
19826129	sorafenib	Heng DY	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.	Journal of clinical oncology 	2009	268
19862815	sorafenib	Jonasch E	Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis.	Cancer	2010	41
20006922	sorafenib	Izzedine H	VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management.	European journal of cancer	2010	42
20651059	sorafenib	Peña C	Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.	Clinical cancer research 	2010	50
21464158	sorafenib	Zurita AJ	A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.	Annals of oncology 	2012	36
22056247	sorafenib	Rini BI	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.	Lancet	2011	329
24019545	sorafenib	Motzer RJ	Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.	Journal of clinical oncology 	2013	59
24556040	sorafenib	Motzer RJ	Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	55
25712526	sorafenib	Zheng B	MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.	Biochemical and biophysical research communications	2015	21
26969090	sorafenib	Haas NB	Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.	Lancet	2016	41
27770556	sorafenib	Parikh ND	Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.	Hepatology	2017	6
16330672	sunitinib	Motzer RJ	Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.	Journal of clinical oncology 	2006	257
17202116	sunitinib	Rini BI	Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.	Journal of the National Cancer Institute	2007	56
17327610	sunitinib	Chow LQ	Sunitinib: from rational design to clinical efficacy.	Journal of clinical oncology 	2007	182
17605814	sunitinib	Deprimo SE	Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.	Journal of translational medicine	2007	91
18669461	sunitinib	Rini BI	Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.	Journal of clinical oncology 	2008	113
18927310	sunitinib	Finke JH	Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.	Clinical cancer research 	2008	126
19224847	sunitinib	Feldman DR	Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.	Journal of clinical oncology 	2009	72
19276286	sunitinib	Ko JS	Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.	Clinical cancer research 	2009	243
19487381	sunitinib	Motzer RJ	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.	Journal of clinical oncology 	2009	449
20103629	sunitinib	Huang D	Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.	Cancer research	2010	63
20103651	sunitinib	Huang D	Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.	Cancer research	2010	114
20406969	sunitinib	Ko JS	Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.	Cancer research	2010	85
20501804	sunitinib	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	56
20657034	sunitinib	Patil S	Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma.	Annals of oncology 	2011	40
20948437	sunitinib	Adotevi O	A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.	Journal of immunotherapy	2010	42
21315783	sunitinib	Finke J	MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.	International immunopharmacology	2011	73
21527770	sunitinib	Rini BI	Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.	Journal of the National Cancer Institute	2011	122
21882181	sunitinib	Kim JJ	Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.	Cancer	2012	37
21898375	sunitinib	Molina AM	Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma.	Cancer	2012	35
22015057	sunitinib	Garcia-Donas J	Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.	The Lancet. Oncology	2011	64
25123505	sunitinib	Mikami S	Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.	International journal of cancer	2015	22
25381264	sunitinib	Ciamporcero E	Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.	Molecular cancer therapeutics	2015	19
25538263	sunitinib	Choueiri TK	Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.	Clinical cancer research 	2015	34
25583177	sunitinib	Beuselinck B	Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.	Clinical cancer research 	2015	18
26201448	sunitinib	Khella HWZ	miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.	Molecular therapy 	2015	15
26364599	sunitinib	Zhou L	Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.	Oncogene	2016	39
26626617	sunitinib	Tannir NM	Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.	European urology	2016	26
26794930	sunitinib	Armstrong AJ	Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.	The Lancet. Oncology	2016	25
27117758	sunitinib	Qu L	Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.	Cancer cell	2016	63
27595394	sunitinib	Chen W	Targeting renal cell carcinoma with a HIF-2 antagonist.	Nature	2016	39
27718781	sunitinib	Ravaud A	Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.	The New England journal of medicine	2016	32
27751729	sunitinib	Hsieh JJ	Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.	European urology	2017	13
28199818	sunitinib	Choueiri TK	Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.	Journal of clinical oncology 	2017	15
26794439	copeptins	Christ-Crain M	Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.	Nature reviews. Endocrinology	2016	12
20008644	pazopanib	Hutson TE	Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma.	Journal of clinical oncology 	2010	65
20100962	pazopanib	Sternberg CN	Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.	Journal of clinical oncology 	2010	509
21576632	pazopanib	Xu CF	Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.	Journal of clinical oncology 	2011	42
22759480	pazopanib	Tran HT	Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.	The Lancet. Oncology	2012	81
19129749	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Komoroski B	Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.	Clinical pharmacology and therapeutics	2009	69
23735727	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	DeFronzo RA	Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.	Diabetes care	2013	34
24067431	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Kohan DE	Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.	Kidney international	2014	79
24257692	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Gilbert RE	Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?	Kidney international	2014	23
24463448	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Merovci A	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.	The Journal of clinical investigation	2014	110
24631482	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Oliva RV	Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.	Journal of the American Society of Hypertension 	2014	38
25246775	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Nauck MA	Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.	Drug design, development and therapy	2014	40
25488697	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Scheen AJ	Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.	Drugs	2015	31
25894829	2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	58
23390498	empagliflozin	Panchapakesan U	Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?	PloS one	2013	38
24334175	empagliflozin	Cherney DZ	Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.	Circulation	2014	136
24795251	empagliflozin	Barnett AH	Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes & endocrinology	2014	70
26180105	empagliflozin	Ferrannini G	Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	24
26861783	empagliflozin	Ferrannini E	Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.	Diabetes	2016	20
26880444	empagliflozin	Rajasekeran H	Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis.	Kidney international	2016	13
27112340	empagliflozin	Sattar N	SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?	Diabetologia	2016	16
27289124	empagliflozin	Mudaliar S	Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.	Diabetes care	2016	43
27299675	empagliflozin	Wanner C	Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.	The New England journal of medicine	2016	143
27878313	empagliflozin	Vallon V	Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.	Diabetologia	2017	15
